Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 546 articles:
HTML format
Text format



Single Articles


    November 2017
  1. MIZZACI CC, Porfirio GJM, Vilela AT, Guillhen JCS, et al
    Retraction notice to "Ivabradine as adjuvant treatment for chronic heart failure" [Int. J. Cardiol. 227 (2017) 43-50].
    Int J Cardiol. 2017;247:55.
    PubMed     Text format    


  2. ISHIDA J, Springer J
    Reply to letter to the editor "suramin against myostatin signaling may be considered to intervene in female patients with advanced heart failure".
    Int J Cardiol. 2017;247:48.
    PubMed     Text format    


  3. WU Y, Sun X
    Suramin against myostatin signaling may be considered to intervene in female patients with advanced heart failure.
    Int J Cardiol. 2017;247:44.
    PubMed     Text format    


  4. YUCEL O, Yucel H, Zorlu A
    D-dimer is a predictor of cardiovascular death, and new-onset atrial fibrillation in patients with systolic heart failure.
    Int J Cardiol. 2017;247:39.
    PubMed     Text format    


  5. GIULIANO C, Neil C, Levinger I
    Letter to the editor: "The frailty syndrome is associated with adverse health outcomes in very old patients with stable heart failure: A prospective study in six Spanish hospitals".
    Int J Cardiol. 2017;246:56.
    PubMed     Text format    


    October 2017
  6. CAMPODONICO J, Cosentino N, Agostoni P
    The "hands-on" patient-centered method: An old approach for a new perspective in acute heart failure.
    Int J Cardiol. 2017;245:213-214.
    PubMed     Text format    


  7. TAVAZZI G, Neskovic AN, Hussain A, Volpicelli G, et al
    A plea for an early ultrasound-clinical integrated approach in patients with acute heart failure. A proactive comment on the ESC Guidelines on Heart Failure 2016.
    Int J Cardiol. 2017;245:207-210.
    PubMed     Text format     Abstract available


    September 2017
  8. XUAN W, Huang W, Wang R, Chen C, et al
    Elevated circulating IL-32 presents a poor prognostic outcome in patients with heart failure after myocardial infarction.
    Int J Cardiol. 2017;243:367-373.
    PubMed     Text format     Abstract available


  9. YAMADA S, Lo LW, Chen SA
    Reply to letter to the editor: "A potential and lionhearted soldier for atrial fibrillation accompanied with heart failure: Renal denervation".
    Int J Cardiol. 2017;243:282.
    PubMed     Text format    


  10. YI X, Feng G, Jiang X
    A potential and lionhearted soldier for atrial fibrillation accompanied with heart failure: Renal denervation.
    Int J Cardiol. 2017;243:281.
    PubMed     Text format    


  11. WAKILI R, Dobrev D
    Role of triggers and substrate in heart failure based atrial fibrillation: Is pulmonary vein isolation still the cornerstone of atrial fibrillation therapy?
    Int J Cardiol. 2017;243:276-278.
    PubMed     Text format    


  12. VAINSHELBOIM B, Amin A, Christle JW, Hebbal S, et al
    A method for determining exercise oscillatory ventilation in heart failure: Prognostic value and practical implications.
    Int J Cardiol. 2017 Sep 14. pii: S0167-5273(17)32062.
    PubMed     Text format     Abstract available


  13. WANG S, Su Z, Wu Z, Yu Q, et al
    Assessment of current use of guideline-based medical therapy in elderly patients with heart failure.
    Int J Cardiol. 2017;242:34.
    PubMed     Text format    


    August 2017
  14. AGRICOLA E, Marini C
    Corrigendum to "Lung ultrasound predicts decompensation in heart failure outpatients: Another piece to the puzzle but still an incomplete picture" [Int. J. Cardiol. 240 (2017) 324-325].
    Int J Cardiol. 2017 Aug 28. pii: S0167-5273(17)34425.
    PubMed     Text format    


  15. VERSCHURE DO, de Groot JR, Mirzaei S, Gheysens O, et al
    Cardiac 123I-mIBG scintigraphy is associated with freedom of appropriate ICD therapy in stable chronic heart failure patients.
    Int J Cardiol. 2017 Aug 25. pii: S0167-5273(17)33211.
    PubMed     Text format     Abstract available


  16. CHIN A, Ntsekhe M, Viljoen C, Rossouw J, et al
    Rationale and design of a prospective study to assess the effect of left cardiac sympathetic denervation in chronic heart failure.
    Int J Cardiol. 2017 Aug 8. pii: S0167-5273(17)34427.
    PubMed     Text format     Abstract available


  17. PARK JJ, Cho YJ, Oh IY, Park HA, et al
    Short and long-term prognostic value of hyponatremia in heart failure with preserved ejection fraction versus reduced ejection fraction: An analysis of the Korean Acute Heart Failure registry.
    Int J Cardiol. 2017 Aug 5. pii: S0167-5273(17)33597.
    PubMed     Text format     Abstract available


  18. FERNANDEZ-GASSO L, Hernando-Arizaleta L, Palomar-Rodriguez JA, Abellan-Perez MV, et al
    Trends, causes and timing of 30-day readmissions after hospitalization for heart failure: 11-year population-based analysis with linked data.
    Int J Cardiol. 2017 Aug 4. pii: S0167-5273(17)33042.
    PubMed     Text format     Abstract available


  19. RIVA MA, Cesana F, Achilli F, Scordo F, et al
    The "thirsty dropsy": Early descriptions in medical and non-medical authors of thirst as symptom of chronic heart failure.
    Int J Cardiol. 2017 Aug 3. pii: S0167-5273(17)32582.
    PubMed     Text format     Abstract available


  20. AGRICOLA E, Marini C
    Lung ultrasound predicts decompensation in heart failure outpatients: Another piece to the puzzle but still an incomplete picture.
    Int J Cardiol. 2017;240:324-325.
    PubMed     Text format    


  21. MIGLIORANZA MH, Picano E, Badano LP, Sant'Anna R, et al
    Pulmonary congestion evaluated by lung ultrasound predicts decompensation in heart failure outpatients.
    Int J Cardiol. 2017;240:271-278.
    PubMed     Text format     Abstract available


  22. RODRIGUEZ-MANERO M, Cordero A, Kreidieh O, Garcia-Acuna JM, et al
    Proposal of a novel clinical score to predict heart failure incidence in long-term survivors of acute coronary syndromes.
    Int J Cardiol. 2017 Aug 1. pii: S0167-5273(17)31821.
    PubMed     Text format     Abstract available


    July 2017
  23. MOUTON S, Ridon H, Fertin M, Pentiah AD, et al
    2D-speckle tracking right ventricular strain to assess right ventricular systolic function in systolic heart failure. Analysis of the right ventricular free and posterolateral walls.
    Int J Cardiol. 2017 Jul 25. pii: S0167-5273(17)32356.
    PubMed     Text format     Abstract available


  24. KANG SH, Kim J, Park JJ, Oh IY, et al
    Risk of stroke in congestive heart failure with and without atrial fibrillation.
    Int J Cardiol. 2017 Jul 20. pii: S0167-5273(17)30701.
    PubMed     Text format     Abstract available


  25. PEREGO GB, Oldani M, Pellegrini D, Brasca FMA, et al
    Correlation between pulmonary artery pressure and thoracic impedance: Insights from daily monitoring through an implanted device in chronic heart failure.
    Int J Cardiol. 2017 Jul 17. pii: S0167-5273(17)32090.
    PubMed     Text format     Abstract available


  26. WANG JZ, Du WT, Liu GJ
    Limit the uptake of milk by young people: A method to prevent the occurrence of heart failure.
    Int J Cardiol. 2017;239:18.
    PubMed     Text format    


  27. CORBINEAU S, Breton M, Mialet-Perez J, Costemale-Lacoste JF, et al
    Major depression and heart failure: Interest of monoamine oxidase inhibitors.
    Int J Cardiol. 2017 Jul 8. pii: S0167-5273(17)34029.
    PubMed     Text format     Abstract available


  28. GRUSON D, Ferracin B, Ahn SA, Rousseau MF, et al
    Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fraction.
    Int J Cardiol. 2017 Jul 5. pii: S0167-5273(17)30763.
    PubMed     Text format    


  29. AZADANI PN, King JB, Kheirkhahan M, Chang L, et al
    Left atrial fibrosis is associated with new-onset heart failure in patients with atrial fibrillation.
    Int J Cardiol. 2017 Jul 5. pii: S0167-5273(17)32655.
    PubMed     Text format    


    June 2017
  30. DRISCOLL A, Barnes EH, Blankenberg S, Colquhoun DM, et al
    Predictors of incident heart failure in patients after an acute coronary syndrome: The LIPID heart failure risk-prediction model.
    Int J Cardiol. 2017 Jun 30. pii: S0167-5273(16)34461.
    PubMed     Text format     Abstract available


  31. KASAMA S, Toyama T, Kurabayashi M
    Comparative effects of long and short-acting loop diuretics on mortality in patients with chronic heart failure.
    Int J Cardiol. 2017 Jun 15. pii: S0167-5273(17)32016.
    PubMed     Text format     Abstract available


  32. DE FERRARI GM, Stolen C, Tuinenburg AE, Wright DJ, et al
    Long-term vagal stimulation for heart failure: Eighteen month results from the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) trial.
    Int J Cardiol. 2017 Jun 10. pii: S0167-5273(17)31295.
    PubMed     Text format     Abstract available


  33. PENICKA M, Kotrc M, Ondrus T, Mo Y, et al
    Minimally invasive mitral valve annuloplasty confers a long-term survival benefit compared with state-of-the-art treatment in heart failure with functional mitral regurgitation.
    Int J Cardiol. 2017 Jun 8. pii: S0167-5273(17)31033.
    PubMed     Text format     Abstract available


  34. EMDIN M, Aimo A, Vergaro G, Passino C, et al
    Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators.
    Int J Cardiol. 2017;236:348-349.
    PubMed     Text format    


  35. FORMIGA F, Masip J, Chivite D, Corbella X, et al
    Applicability of the heart failure Readmission Risk score: A first European study.
    Int J Cardiol. 2017;236:304-309.
    PubMed     Text format     Abstract available


    May 2017
  36. DIXON DL, De Pasquale CG, Lawrence MD, Cavallaro E, et al
    Lung fluid clearance in chronic heart failure patients.
    Int J Cardiol. 2017 May 26. pii: S0167-5273(16)34040.
    PubMed     Text format     Abstract available


  37. DESTA L, Jernberg T, Spaak J, Hofman-Bang C, et al
    Risk and predictors of readmission for heart failure following a myocardial infarction between 2004 and 2013: A Swedish nationwide observational study.
    Int J Cardiol. 2017 May 24. pii: S0167-5273(16)34867.
    PubMed     Text format     Abstract available


  38. POLZL G, Altenberger J, Baholli L, Beltran P, et al
    Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.
    Int J Cardiol. 2017 May 23. pii: S0167-5273(17)31017.
    PubMed     Text format     Abstract available


  39. BALDI I, Azzolina D, Berchialla P, Gregori D, et al
    Comorbidity-adjusted relative survival in newly hospitalized heart failure patients: A population-based study.
    Int J Cardiol. 2017 May 22. pii: S0167-5273(17)31500.
    PubMed     Text format     Abstract available


  40. AGRA BERMEJO R, Varela Roman A, Gomez Otero I, Gonzalez Ferreiro R, et al
    Letter to editor in response to Formiga et al. "Utility of the Controlling Nutritional Status (CONUT) score in patients admitted due to acute heart failure".
    Int J Cardiol. 2017;235:204.
    PubMed     Text format    


  41. FORMIGA F, Chivite D, Corbella X
    Utility of the Controlling Nutritional Status (CONUT) score in patients admitted due to acute heart failure.
    Int J Cardiol. 2017;235:203.
    PubMed     Text format    


  42. HIDALGO FJ, Anguita M
    Ivabradine in acute decompensated systolic heart failure.
    Int J Cardiol. 2017;235:198.
    PubMed     Text format    


  43. SARGENTO L
    Ivabradine in acute decompensated systolic heart failure.
    Int J Cardiol. 2017;235:197.
    PubMed     Text format    


  44. EYUBOGLU M
    Prognostic factors in the heart failure with reduced ejection fraction.
    Int J Cardiol. 2017;235:187.
    PubMed     Text format    


  45. NIJST P, Verbrugge FH, Martens P, Dupont M, et al
    Renal response to intravascular volume expansion in euvolemic heart failure patients with reduced ejection fraction: Mechanistic insights and clinical implications.
    Int J Cardiol. 2017 May 14. pii: S0167-5273(17)31183.
    PubMed     Text format     Abstract available


  46. CASADO J, Sanchez M, Garces V, Manzano L, et al
    Influence of renal dysfunction phenotype on mortality in decompensated heart failure with preserved and mid-range ejection fraction.
    Int J Cardiol. 2017 May 12. pii: S0167-5273(16)32858.
    PubMed     Text format     Abstract available


  47. ROBERTSON J, Schioler L, Toren K, Soderberg M, et al
    Mental disorders and stress resilience in adolescence and long-term risk of early heart failure among Swedish men.
    Int J Cardiol. 2017 May 10. pii: S0167-5273(16)34479.
    PubMed     Text format     Abstract available


  48. KINGERY JR, Yango M, Wajanga B, Kalokola F, et al
    Heart failure, post-hospital mortality and renal function in Tanzania: A prospective cohort study.
    Int J Cardiol. 2017 May 9. pii: S0167-5273(16)33889.
    PubMed     Text format     Abstract available


  49. TSIMPLOULIS A, Sheriff HM, Lam PH, Dooley DJ, et al
    Corrigendum to "Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study" [Int. J. Cardiol. 235 (2017) 11-16].
    Int J Cardiol. 2017 May 6. pii: S0167-5273(17)32436.
    PubMed     Text format    


  50. TURCATO G, Zorzi E, Prati D, Ricci G, et al
    Early in-hospital variation of red blood cell distribution width predicts mortality in patients with acute heart failure.
    Int J Cardiol. 2017 May 6. pii: S0167-5273(17)31187.
    PubMed     Text format     Abstract available


  51. AKITA K, Kohno T, Kohsaka S, Mizuno A, et al
    Author's reply: Assessment of current use of guideline-based medical therapy in elderly patients with heart failure.
    Int J Cardiol. 2017 May 6. pii: S0167-5273(17)32618.
    PubMed     Text format    


  52. MOLINER P, Jankowska EA, van Veldhuisen DJ, Farre N, et al
    Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure.
    Int J Cardiol. 2017 May 3. pii: S0167-5273(16)33235.
    PubMed     Text format     Abstract available


  53. MORPURGO M, Pasqualini M, Brunazzi MC, Vianello G, et al
    A multicenter feasibility study on ultrafiltration via a single peripheral venous access in acute heart failure with overt fluid overload.
    Int J Cardiol. 2017 May 2. pii: S0167-5273(16)33118.
    PubMed     Text format     Abstract available


  54. IACOVIELLO M, Monitillo F, Citarelli G, Leone M, et al
    Right ventriculo-arterial coupling assessed by two-dimensional strain: A new parameter of right ventricular function independently associated with prognosis in chronic heart failure patients.
    Int J Cardiol. 2017 May 1. pii: S0167-5273(16)33807.
    PubMed     Text format     Abstract available


    April 2017
  55. MIZUNO A, Iguchi H, Sawada Y, Hurley M, et al
    The impact of carperitide usage on the cost of hospitalization and outcome in patients with acute heart failure: High value care vs. low value care campaign in Japan.
    Int J Cardiol. 2017 Apr 26. pii: S0167-5273(17)30779.
    PubMed     Text format     Abstract available


  56. KIMURA Y, Noda T, Matsuyama TA, Otsuka Y, et al
    Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: What are the risk factors?
    Int J Cardiol. 2017 Apr 21. pii: S0167-5273(17)30192.
    PubMed     Text format     Abstract available


  57. SANTAS E, de la Espriella-Juan R, Mollar A, Valero E, et al
    Echocardiographic pulmonary artery pressure estimation and heart failure rehospitalization burden in patients with acute heart failure.
    Int J Cardiol. 2017 Apr 21. pii: S0167-5273(17)30752.
    PubMed     Text format     Abstract available


  58. ZUGCK C, Stork S, Stockl G
    Long-term treatment with ivabradine over 12months in patients with chronic heart failure in clinical practice: Effect on symptoms, quality of life and hospitalizations.
    Int J Cardiol. 2017 Apr 10. pii: S0167-5273(17)30114.
    PubMed     Text format     Abstract available


  59. ISHIDA J, Konishi M, Saitoh M, Anker M, et al
    Myostatin signaling is up-regulated in female patients with advanced heart failure.
    Int J Cardiol. 2017 Apr 4. pii: S0167-5273(17)32064.
    PubMed     Text format     Abstract available


  60. AKODAD M, Fauconnier J, Sicard P, Huet F, et al
    Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model.
    Int J Cardiol. 2017 Apr 1. pii: S0167-5273(16)34092.
    PubMed     Text format     Abstract available


  61. SAITOH M, Ishida J, Doehner W, von Haehling S, et al
    Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016.
    Int J Cardiol. 2017 Apr 1. pii: S0167-5273(17)32066.
    PubMed     Text format     Abstract available


    March 2017
  62. MENDES LV, Gonsalez SR, Oliveira-Pinto LM, Pereira-Acacio A, et al
    Long-term effect of a chronic low-protein multideficient diet on the heart: Hypertension and heart failure in chronically malnourished young adult rats.
    Int J Cardiol. 2017 Mar 27. pii: S0167-5273(17)31864.
    PubMed     Text format     Abstract available


  63. HERNAN GOMEZ LLAMBI H, Cao G, Donato M, Suarez D, et al
    Left ventricular hypertrophy does not prevent heart failure in experimental hypertension.
    Int J Cardiol. 2017 Mar 27. pii: S0167-5273(17)31863.
    PubMed     Text format     Abstract available


  64. TSENG WC, Liu JS, Hung SC, Kuo KL, et al
    Effect of spironolactone on the risks of mortality and hospitalization for heart failure in pre-dialysis advanced chronic kidney disease: A nationwide population-based study.
    Int J Cardiol. 2017 Mar 18. pii: S0167-5273(17)31725.
    PubMed     Text format     Abstract available


  65. RINKUNIENE D, Krivickiene A, Laukaitiene J, Jurkevicius R, et al
    Pharmacological treatment changes of chronic heart failure during cardiac resynchronization therapy: A 1-year follow-up study.
    Int J Cardiol. 2017 Mar 14. pii: S0167-5273(17)31610.
    PubMed     Text format     Abstract available


  66. LOURENCO P, Silva S, Cunha F, Pereira J, et al
    Dipeptidyl peptidase-IV in chronic heart failure with reduced ejection fraction.
    Int J Cardiol. 2017 Mar 11. pii: S0167-5273(16)33739.
    PubMed     Text format     Abstract available


  67. PASCUAL-FIGAL DA, Ferrero-Gregori A, Gomez-Otero I, Vazquez R, et al
    Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure.
    Int J Cardiol. 2017 Mar 9. pii: S0167-5273(17)30596.
    PubMed     Text format     Abstract available


  68. FROHLICH H, Raman N, Tager T, Schellberg D, et al
    Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure.
    Int J Cardiol. 2017 Mar 9. pii: S0167-5273(17)31523.
    PubMed     Text format     Abstract available


  69. BONSU KO, Owusu IK, Buabeng KO, Reidpath DD, et al
    Clinical characteristics and prognosis of patients admitted for heart failure: A 5-year retrospective study of African patients.
    Int J Cardiol. 2017 Mar 6. pii: S0167-5273(17)31424.
    PubMed     Text format     Abstract available


  70. AMIR O, Ben-Gal T, Weinstein JM, Schliamser J, et al
    Evaluation of remote dielectric sensing (ReDS) technology-guided therapy for decreasing heart failure re-hospitalizations.
    Int J Cardiol. 2017 Mar 3. pii: S0167-5273(16)32225.
    PubMed     Text format     Abstract available


  71. MONAHAN M, Barton P, Taylor CJ, Roalfe AK, et al
    MICE or NICE? An economic evaluation of clinical decision rules in the diagnosis of heart failure in primary care.
    Int J Cardiol. 2017 Mar 2. pii: S0167-5273(16)33702.
    PubMed     Text format     Abstract available


  72. TSIMPLOULIS A, Sheriff HM, Lam PH, Dooley DJ, et al
    Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study.
    Int J Cardiol. 2017 Mar 1. pii: S0167-5273(17)31290.
    PubMed     Text format     Abstract available


  73. SHERIFF HM, Tsimploulis A, Valentova M, Anker MS, et al
    Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study.
    Int J Cardiol. 2017 Mar 1. pii: S0167-5273(17)31293.
    PubMed     Text format     Abstract available


    February 2017
  74. USZKO-LENCER NH, Mesquita R, Janssen E, Werter C, et al
    Reliability, construct validity and determinants of 6-minute walk test performance in patients with chronic heart failure.
    Int J Cardiol. 2017 Feb 28. pii: S0167-5273(16)32866.
    PubMed     Text format     Abstract available


  75. ABI KHALIL C, Sulaiman K, Singh R, Jayyousi A, et al
    BMI is inversely correlated to the risk of mortality in patients with type 2 diabetes hospitalized for acute heart failure: Findings from the Gulf aCute heArt failuRE (Gulf-CARE) registry.
    Int J Cardiol. 2017 Feb 27. pii: S0167-5273(16)34386.
    PubMed     Text format     Abstract available


  76. AKITA K, Kohno T, Kohsaka S, Shiraishi Y, et al
    Current use of guideline-based medical therapy in elderly patients admitted with acute heart failure with reduced ejection fraction and its impact on event-free survival.
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31098.
    PubMed     Text format     Abstract available


  77. ALHABEEB W, Elasfar A, AlBackr H, AlShaer F, et al
    Clinical characteristics, management and outcomes of patients with chronic heart failure: Results from the heart function assessment registry trial in Saudi Arabia (HEARTS-chronic).
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31118.
    PubMed     Text format     Abstract available


  78. YAMADA S, Lo LW, Chou YH, Lin WL, et al
    Renal denervation regulates the atrial arrhythmogenic substrates through reverse structural remodeling in heart failure rabbit model.
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31114.
    PubMed     Text format     Abstract available


  79. VAN BOVEN N, Akkerhuis KM, Anroedh SS, Rizopoulos D, et al
    Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(17)31107.
    PubMed     Text format     Abstract available


  80. SZMIT S, Jurczak W, Zaucha JM, Dlugosz-Danecka M, et al
    Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(17)31101.
    PubMed     Text format     Abstract available


  81. ANSELMINO M, Matta M, Bunch TJ, Fiala M, et al
    Conduction recovery following catheter ablation in patients with recurrent atrial fibrillation and heart failure.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(16)33338.
    PubMed     Text format     Abstract available


  82. AMIN A, von Haehling S
    Updates in heart failure: Highlights from the Iranian Joint Cardiovascular Congress Tehran, Iran, 1-4 March 2016.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(17)31117.
    PubMed     Text format    


  83. MAFFESSANTI F, Wanten J, Potse M, Regoli F, et al
    The relation between local repolarization and T-wave morphology in heart failure patients.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(16)34312.
    PubMed     Text format     Abstract available


  84. YOSHIDA M, Ando SI, Kodama K, Ebihara K, et al
    Adaptive servo-ventilation therapy reduces hospitalization rate in patients with severe heart failure.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(17)31105.
    PubMed     Text format     Abstract available


  85. FRIGERIO M, Mazzali C, Paganoni AM, Ieva F, et al
    Trends in heart failure hospitalizations, patient characteristics, in-hospital and 1-year mortality: A population study, from 2000 to 2012 in Lombardy.
    Int J Cardiol. 2017 Feb 21. pii: S0167-5273(16)34743.
    PubMed     Text format     Abstract available


  86. KARLSTROM P, Johansson P, Dahlstrom U, Boman K, et al
    The impact of time to heart failure diagnosis on outcomes in patients tailored for heart failure treatment by use of natriuretic peptides. Results from the UPSTEP study.
    Int J Cardiol. 2017 Feb 17. pii: S0167-5273(16)33177.
    PubMed     Text format     Abstract available


  87. RIZZI MA, Alquezar Arbe A, Martin Marcuello J, Hernandez Ontiveros H, et al
    Delirium in heart failure.
    Int J Cardiol. 2017;229:132.
    PubMed     Text format    


  88. COWIE MR, Lopatin YM, Saldarriaga C, Fonseca C, et al
    The Optimize Heart Failure Care Program: Initial lessons from global implementation.
    Int J Cardiol. 2017 Feb 12. pii: S0167-5273(17)30746.
    PubMed     Text format     Abstract available


  89. DENFELD QE, Winters-Stone K, Mudd JO, Gelow JM, et al
    The prevalence of frailty in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2017 Feb 10. pii: S0167-5273(16)32977.
    PubMed     Text format     Abstract available


  90. RODRIGUEZ-PASCUAL C, Paredes-Galan E, Ferrero-Martinez AI, Gonzalez-Guerrero JL, et al
    The frailty syndrome is associated with adverse health outcomes in very old patients with stable heart failure: A prospective study in six Spanish hospitals.
    Int J Cardiol. 2017 Feb 8. pii: S0167-5273(16)34474.
    PubMed     Text format     Abstract available


  91. OLIVIER A, Girerd N, Michel JB, Ketelslegers JM, et al
    Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Pos
    Int J Cardiol. 2017 Feb 8. pii: S0167-5273(16)32115.
    PubMed     Text format     Abstract available


    January 2017
  92. KHALID U, Wruck LM, Quibrera PM, Bozkurt B, et al
    BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
    Int J Cardiol. 2017 Jan 31. pii: S0167-5273(17)30599.
    PubMed     Text format     Abstract available


  93. ZHANG J, Wong KY, Clark AL, Cleland JG, et al
    Exploring the relation between changes in NT-proBNP and renal function in patients with suspected heart failure using structural equation modelling.
    Int J Cardiol. 2017 Jan 27. pii: S0167-5273(17)30557.
    PubMed     Text format     Abstract available


  94. SWEDBERG K, Bohm M, Borer JS, Ford I, et al
    Comments on meta-analysis of ivabradine as adjuvant treatment for chronic heart failure by Mizzaci et al.
    Int J Cardiol. 2017 Jan 23. pii: S0167-5273(16)34108.
    PubMed     Text format    


  95. BOTTO GL, Padeletti L, Covino G, Pieragnoli P, et al
    Electrical treatment of atrial arrhythmias in heart failure patients implanted with a dual defibrillator CRT device. Results from the TRADE-HF study.
    Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)33105.
    PubMed     Text format     Abstract available


  96. NAGAO K, Tamura A, Morimoto T, Shimamura K, et al
    Liver fibrogenesis marker, 7S domain of collagen type IV in patients with acutely decompensated heart failure: Correlates, prognostic value and time course.
    Int J Cardiol. 2017 Jan 15. pii: S0167-5273(16)33698.
    PubMed     Text format     Abstract available


  97. ZHANG X, Cheng HJ, Zhou P, Kitzman DW, et al
    Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure.
    Int J Cardiol. 2017 Jan 10. pii: S0167-5273(16)33227.
    PubMed     Text format     Abstract available


  98. KISHIMOTO S, Kajikawa M, Maruhashi T, Iwamoto Y, et al
    Endothelial dysfunction and abnormal vascular structure are simultaneously present in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(16)32405.
    PubMed     Text format     Abstract available


  99. ZYMLINSKI R, Sokolski M, Siwolowski P, Biegus J, et al
    Elevated troponin I level assessed by a new high-sensitive assay and the risk of poor outcomes in patients with acute heart failure.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30031.
    PubMed     Text format     Abstract available


  100. KONTOGEORGOS S, Thunstrom E, Johansson MC, Fu M, et al
    Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30080.
    PubMed     Text format     Abstract available


  101. MARTINEZ F, Martinez-Ibanez L, Pichler G, Ruiz A, et al
    Multimorbidity and acute heart failure in internal medicine.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30039.
    PubMed     Text format     Abstract available


  102. VON BIBRA H, Strohle A, St John Sutton M, Worm N, et al
    Dietary therapy in heart failure with preserved ejection fraction and/or left ventricular diastolic dysfunction in patients with metabolic syndrome.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30022.
    PubMed     Text format     Abstract available


  103. HARJOLA P, Boyd J, Tarvasmaki T, Mattila J, et al
    The impact of emergency medical services in acute heart failure.
    Int J Cardiol. 2017 Jan 4. pii: S0167-5273(17)30036.
    PubMed     Text format     Abstract available


    December 2016
  104. YANG Y, Huang WL, Yang J, Yang J, et al
    5-Methoxytryptophan: A promising early marker for predicting post-myocardial infarction heart failure.
    Int J Cardiol. 2016 Dec 29. pii: S0167-5273(16)34194.
    PubMed     Text format    


  105. KORATALA A, Jain A, Kazory A
    Ultrafiltration does provide more efficient decongestion compared to conventional treatment for acute heart failure.
    Int J Cardiol. 2016 Dec 28. pii: S0167-5273(16)34131.
    PubMed     Text format    


  106. LARSSON SC, Wallin A, Wolk A
    Contrasting association between alcohol consumption and risk of myocardial infarction and heart failure: Two prospective cohorts.
    Int J Cardiol. 2016 Dec 28. pii: S0167-5273(16)33141.
    PubMed     Text format     Abstract available


  107. PEARSON MJ, Smart NA
    Effect of exercise training on endothelial function in heart failure patients: A systematic review meta-analysis.
    Int J Cardiol. 2016 Dec 28. pii: S0167-5273(16)32418.
    PubMed     Text format     Abstract available


  108. CORREALE M, Carpagnano GE, Brunetti ND, Forte L, et al
    Respiratory drive in patients with chronic heart failure and central sleep apnea: Data from the Daunia Heart Failure Registry.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34823.
    PubMed     Text format    


  109. SANCHEZ-GIL J, Manzano L, Flather M, Formiga F, et al
    Combining heart rate and systolic blood pressure to improve risk stratification in older patients with heart failure: Findings from the RICA Registry.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34527.
    PubMed     Text format     Abstract available


  110. KATAOKA H
    Vascular expansion during worsening of heart failure: Effects on clinical features and its determinants.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34547.
    PubMed     Text format     Abstract available


  111. LIN YH, Kuo CC, Wu KK
    Reply to letter: "5-Methoxytryptophan: A promising early marker for predicting post-myocardial infarction heart failure".
    Int J Cardiol. 2016 Dec 26. pii: S0167-5273(16)34776.
    PubMed     Text format    


  112. ASANO R, Kajimoto K, Oka T, Sugiura R, et al
    Association of New York Heart Association functional class IV symptoms at admission and clinical features with outcomes in patients hospitalized for acute heart failure syndromes.
    Int J Cardiol. 2016 Dec 26. pii: S0167-5273(16)34539.
    PubMed     Text format     Abstract available


  113. XANTHOPOULOS A, Giamouzis G, Tryposkiadis K, Paraskevopoulou E, et al
    A simple score for early risk stratification in acute heart failure.
    Int J Cardiol. 2016 Dec 22. pii: S0167-5273(16)34584.
    PubMed     Text format     Abstract available


  114. LIN TY, Chen CY, Huang YB
    Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34589.
    PubMed     Text format     Abstract available


  115. IWAKAMI N, Nagai T, Furukawa TA, Sugano Y, et al
    Prognostic value of malnutrition assessed by Controlling Nutritional Status score for long-term mortality in patients with acute heart failure.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34552.
    PubMed     Text format     Abstract available


  116. SEGUCHI O, Hisamatsu E, Nakano A, Nakajima S, et al
    Low partial pressure of end-tidal carbon dioxide predicts left ventricular assist device implantation in patients with advanced chronic heart failure.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34593.
    PubMed     Text format     Abstract available


  117. CHEN Y, Cai L, Du Z, Xu J, et al
    Dipstick proteinuria is a prognostic indicator of short-term mortality in patients with heart failure.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34587.
    PubMed     Text format     Abstract available


  118. IKEDA Y, Ishii S, Fujita T, Iida Y, et al
    Prognostic impact of intestinal wall thickening in hospitalized patients with heart failure.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34551.
    PubMed     Text format     Abstract available


  119. OKABE T, Yakushiji T, Kido T, Oyama Y, et al
    Relationship between worsening renal function and long-term cardiovascular mortality in heart failure patients.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34592.
    PubMed     Text format     Abstract available


  120. KOELL B, Zotter-Tufaro C, Duca F, Kammerlander AA, et al
    Fluid status and outcome in patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34570.
    PubMed     Text format     Abstract available


  121. WANNAMETHEE SG, Whincup PH, Papacosta O, Lennon L, et al
    Associations between blood coagulation markers, NT-proBNP and risk of incident heart failure in older men: The British Regional Heart Study.
    Int J Cardiol. 2016 Dec 20. pii: S0167-5273(16)34544.
    PubMed     Text format     Abstract available


  122. FONSECA R, Otahal P, Galligan J, Neilson S, et al
    Association of survival time with transthoracic echocardiography in stable patients with heart failure: Is routine follow-up ever appropriate?
    Int J Cardiol. 2016 Dec 20. pii: S0167-5273(16)34529.
    PubMed     Text format     Abstract available


  123. OMAR HR, Guglin M
    Acute systolic heart failure with normal admission BNP: clinical features and outcomes.
    Int J Cardiol. 2016 Dec 20. pii: S0167-5273(16)34558.
    PubMed     Text format     Abstract available


  124. AGRA BERMEJO RM, Gonzalez Ferreiro R, Varela Roman A, Gomez Otero I, et al
    Nutritional status is related to heart failure severity and hospital readmissions in acute heart failure.
    Int J Cardiol. 2016 Dec 19. pii: S0167-5273(16)34557.
    PubMed     Text format     Abstract available


  125. HONDA S, Nagai T, Anzai T
    Reply to "delirium in heart failure".
    Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)34253.
    PubMed     Text format    


    November 2016
  126. ASCHAUER S, Zotter-Tufaro C, Duca F, Kammerlander A, et al
    Modes of death in patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2016;228:422-426.
    PubMed     Text format     Abstract available


  127. AREVALO-LORIDO JC, Carretero-Gomez J, Manzano-Espinosa L
    Reply to the Letter to Editor "Hyposmolarity may be also associated with worse outcomes in patients with heart failure".
    Int J Cardiol. 2016 Nov 17. pii: S0167-5273(16)33930.
    PubMed     Text format    


  128. BERARDINI A, Biagini E, Saia F, Stolfo D, et al
    Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure?
    Int J Cardiol. 2016;228:191-197.
    PubMed     Text format     Abstract available


  129. SHEN Y, Du K
    Hyposmolarity may be also associated with worse outcomes in patients with heart failure.
    Int J Cardiol. 2016 Nov 12. pii: S0167-5273(16)32987.
    PubMed     Text format    


  130. OMAR HR, Guglin M
    Mitral annulus diameter is the main echocardiographic correlate of S3 gallop in acute heart failure.
    Int J Cardiol. 2016;228:834-836.
    PubMed     Text format    


  131. FUKUTA H, Goto T, Wakami K, Ohte N, et al
    The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: A meta-analysis of observational cohort and randomized controlled studies.
    Int J Cardiol. 2016;228:4-10.
    PubMed     Text format     Abstract available


  132. LEE YC, Chang CH, Dong YH, Lin JW, et al
    Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study.
    Int J Cardiol. 2016;228:1007-1014.
    PubMed     Text format     Abstract available


  133. MIZZACI CC, Porfirio GJ, Vilela AT, Guillhen JC, et al
    Ivabradine as adjuvant treatment for chronic heart failure.
    Int J Cardiol. 2016;227:43-50.
    PubMed     Text format     Abstract available


  134. MENG Y, Liu X, Liu J, Cheng X, et al
    A prospective study on the impact of heart rate control achieved with metoprolol on cardiac performance, motor function and quality of life in Chinese chronic heart failure patients.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33574.
    PubMed     Text format     Abstract available


  135. SINNING C, Kempf T, Schwarzl M, Lanfermann S, et al
    Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33567.
    PubMed     Text format     Abstract available


  136. ADACHI H, Katsuyama H, Yanai H
    The low dose (7.5mg/day) pioglitazone is beneficial to the improvement in metabolic parameters without weight gain and an increase of risk for heart failure.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33586.
    PubMed     Text format    


  137. ZHENG YR, Ye LF, Cen XJ, Lin JY, et al
    Low NT-proBNP levels: An early sign for the diagnosis of ischemic heart failure.
    Int J Cardiol. 2016;228:666-671.
    PubMed     Text format     Abstract available


  138. HAJDUSEK P, Kotrc M, Kautzner J, Melenovsky V, et al
    Heart rate response to exercise in heart failure patients: The prognostic role of metabolic-chronotropic relation and heart rate recovery.
    Int J Cardiol. 2016;228:588-593.
    PubMed     Text format     Abstract available


  139. ALAGIAKRISHNAN K, Mah D, Dyck JR, Senthilselvan A, et al
    Comparison of two commonly used clinical cognitive screening tests to diagnose mild cognitive impairment in heart failure with the golden standard European Consortium Criteria.
    Int J Cardiol. 2016;228:558-562.
    PubMed     Text format     Abstract available


  140. GOGGINS WB, Chan EY
    A study of the short-term associations between hospital admissions and mortality from heart failure and meteorological variables in Hong Kong: Weather and heart failure in Hong Kong.
    Int J Cardiol. 2016;228:537-542.
    PubMed     Text format     Abstract available


  141. AGRA RM, Varela-Roman A, Gonzalez-Ferreiro R, Vinuela JE, et al
    Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure.
    Int J Cardiol. 2016;228:488-494.
    PubMed     Text format     Abstract available


  142. MUNIBARI AN, Al-Motarreb A, Al-Sagheer N, Hadi HA, et al
    Clinical characteristics and outcomes of Yemeni patients with acute heart failure aged 50years or younger: Data from Gulf Acute Heart Failure Registry (Gulf CARE).
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)32093.
    PubMed     Text format     Abstract available


  143. AL-KHATEEB M, Qureshi WT, Odeh R, Ahmed AM, et al
    The impact of digoxin on mortality in patients with chronic systolic heart failure: A propensity-matched cohort study.
    Int J Cardiol. 2016;228:214-218.
    PubMed     Text format     Abstract available


  144. OTAKI Y, Watanabe T, Kinoshita D, Yokoyama M, et al
    Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure.
    Int J Cardiol. 2016;228:151-157.
    PubMed     Text format     Abstract available


  145. KULARATNA S, Byrnes J, Chan YK, Carrington MJ, et al
    Comparison of contemporaneous responses for EQ-5D-3L and Minnesota Living with Heart Failure; a case for disease specific multiattribute utility instrument in cardiovascular conditions.
    Int J Cardiol. 2016;227:172-176.
    PubMed     Text format     Abstract available


  146. TSAI MY, Hu WL, Lin CC, Lee YC, et al
    Prescription pattern of Chinese herbal products for heart failure in Taiwan: A population-based study.
    Int J Cardiol. 2016;228:90-96.
    PubMed     Text format     Abstract available


  147. STRAUSS E, Supinski W, Radziemski A, Oszkinis G, et al
    Is hyperhomocysteinemia a causal factor for heart failure? The impact of the functional variants of MTHFR and PON1 on ischemic and non-ischemic etiology.
    Int J Cardiol. 2016;228:37-44.
    PubMed     Text format     Abstract available


  148. KWOK CS, Wong CW, Rushton CA, Ahmed F, et al
    Ultrafiltration for acute decompensated cardiac failure: A systematic review and meta-analysis.
    Int J Cardiol. 2016;228:122-128.
    PubMed     Text format     Abstract available


  149. STOLLBERGER C, Schneider B
    Concerns about the ESC heart failure guidelines.
    Int J Cardiol. 2016;228:707-708.
    PubMed     Text format    


  150. USZKO-LENCER NH, Frankenstein L, Spruit MA, Maeder MT, et al
    Predicting hospitalization and mortality in patients with heart failure: The BARDICHE-index.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33581.
    PubMed     Text format     Abstract available


  151. TAMARGO J, Rosano GM, Delpon E, Ruilope L, et al
    Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33583.
    PubMed     Text format     Abstract available


  152. JACOB J, Tost J, Miro O, Herrero P, et al
    Impact of chronic obstructive pulmonary disease on clinical course after an episode of acute heart failure. EAHFE-COPD study.
    Int J Cardiol. 2016 Nov 8. pii: S0167-5273(16)33443.
    PubMed     Text format     Abstract available


  153. HIRAKAWA K, Yamamuro M, Uemura T, Takashio S, et al
    Correlation between microvascular dysfunction and B-type natriuretic peptide levels in non-ischemic heart failure patients with cardiac fibrosis.
    Int J Cardiol. 2016;228:881-885.
    PubMed     Text format     Abstract available


  154. GIULIANO C, Karahalios A, Neil C, Allen J, et al
    The effects of resistance training on muscle strength, quality of life and aerobic capacity in patients with chronic heart failure - A meta-analysis.
    Int J Cardiol. 2016 Nov 7. pii: S0167-5273(16)33469.
    PubMed     Text format     Abstract available


  155. LAM PH, Dooley DJ, Inampudi C, Arundel C, et al
    Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone.
    Int J Cardiol. 2016 Nov 4. pii: S0167-5273(16)33408.
    PubMed     Text format     Abstract available


  156. KAZORY A
    The lower risk of de novo heart failure associated with peritoneal dialysis; the timing does matter.
    Int J Cardiol. 2016 Nov 2. pii: S0167-5273(16)33043.
    PubMed     Text format    


  157. OLDENBURG O, Coats A
    CSA Is Not Beneficial Long Term in Heart Failure Patients with Reduced Ejection Fraction.
    Int J Cardiol. 2016 Nov 2. pii: S0167-5273(16)33404.
    PubMed     Text format     Abstract available


    October 2016
  158. ARIMURA T, Saku K, Kakino T, Nishikawa T, et al
    Intravenous electrical vagal nerve stimulation prior to coronary reperfusion in a canine ischemia-reperfusion model markedly reduces infarct size and prevents subsequent heart failure.
    Int J Cardiol. 2016 Oct 29. pii: S0167-5273(16)33267.
    PubMed     Text format     Abstract available


  159. BRENNER S, Christa M, Berliner D, Deubner N, et al
    Frequency and prognostic impact of mid-expiratory flow reduction in stable patients six months after hospitalisation for heart failure with reduced ejection fraction.
    Int J Cardiol. 2016 Oct 28. pii: S0167-5273(16)33245.
    PubMed     Text format     Abstract available


  160. WANG IK, Lin CL, Sung FC
    Lower risk of de novo congestive heart failure in peritoneal dialysis patients compared with hemodialysis patients.
    Int J Cardiol. 2016 Oct 27. pii: S0167-5273(16)33116.
    PubMed     Text format    


  161. METRA M, Carubelli V, Ravera A, Stewart Coats AJ, et al
    Heart failure 2016: still more questions than answers.
    Int J Cardiol. 2016 Oct 26. pii: S0167-5273(16)33156.
    PubMed     Text format     Abstract available


  162. TOYODA S, Haruyama A, Inami S, Amano H, et al
    Protective effects of bisoprolol against myocardial injury and pulmonary dysfunction in patients with chronic heart failure.
    Int J Cardiol. 2016;226:71-76.
    PubMed     Text format     Abstract available


  163. CHENG S, Wang H, Lu M, Cui C, et al
    The value of CMR for determination of heart failure etiology: An unusual case with histology validation.
    Int J Cardiol. 2016;226:38-41.
    PubMed     Text format    


  164. SAVARESE G, Donal E, Hage C, Oger E, et al
    Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study.
    Int J Cardiol. 2016;226:65-70.
    PubMed     Text format     Abstract available


  165. BOULOGNE M, Sadoune M, Launay JM, Baudet M, et al
    Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction.
    Int J Cardiol. 2016;226:53-59.
    PubMed     Text format     Abstract available


  166. CUI X, Zhou J, Jin X, Zhou J, et al
    Prevalence and correlates of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in elderly community residents.
    Int J Cardiol. 2016 Oct 17. pii: S0167-5273(16)33012.
    PubMed     Text format     Abstract available


  167. STAFYLAS P, Farmakis D, Kourlaba G, Giamouzis G, et al
    The heart failure pandemic: The clinical and economic burden in Greece.
    Int J Cardiol. 2016 Oct 17. pii: S0167-5273(16)33013.
    PubMed     Text format     Abstract available


  168. ACANFORA D, Scicchitano P, Casucci G, Lanzillo B, et al
    Exercise training effects on elderly and middle-age patients with chronic heart failure after acute decompensation: A randomized, controlled trial.
    Int J Cardiol. 2016;225:313-323.
    PubMed     Text format     Abstract available


  169. REYNOLDS JO, Quick AP, Wang Q, Beavers DL, et al
    Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca2+ release.
    Int J Cardiol. 2016;225:371-380.
    PubMed     Text format     Abstract available


  170. CARUBELLI V, Cotter G, Davison B, Gishe J, et al
    In-hospital worsening heart failure in patients admitted for acute heart failure.
    Int J Cardiol. 2016;225:353-361.
    PubMed     Text format     Abstract available


  171. OMAR HR, Guglin M
    Community acquired versus hospital acquired hyponatremia in acute heart failure: Association with clinical characteristics and outcomes.
    Int J Cardiol. 2016;225:247-249.
    PubMed     Text format    


  172. SAITOH M, Dos Santos MR, Anker M, Anker SD, et al
    Neuromuscular electrical stimulation for muscle wasting in heart failure patients.
    Int J Cardiol. 2016;225:200-205.
    PubMed     Text format     Abstract available


    September 2016
  173. BERKVENS CP, Mommersteeg PM
    Letter to the editor: Is an ischemic etiology especially detrimental for women with heart failure?
    Int J Cardiol. 2016 Sep 30. pii: S0167-5273(16)32162.
    PubMed     Text format    


  174. MASUTANI S, Kuwata S, Kurishima C, Iwamoto Y, et al
    Ventricular-vascular dynamics in pediatric patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2016;225:306-312.
    PubMed     Text format     Abstract available


  175. BROWN LA, Boos CJ
    Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulant.
    Int J Cardiol. 2016 Sep 30. pii: S0167-5273(16)32512.
    PubMed     Text format     Abstract available


  176. BATLLE M, Campos B, Farrero M, Cardona M, et al
    Use of serum levels of high sensitivity troponin T, galectin-3 and C-terminal propeptide of type I procollagen at long term follow-up in heart failure patients with reduced ejection fraction: Comparison with soluble AXL and BNP.
    Int J Cardiol. 2016;225:113-119.
    PubMed     Text format     Abstract available


  177. SALZANO A, Marra AM, Ferrara F, Arcopinto M, et al
    Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;225:1-3.
    PubMed     Text format    


  178. ROCHA A, Arbex FF, Alencar MC, Sperandio PA, et al
    Physiological and sensory consequences of exercise oscillatory ventilation in heart failure-COPD.
    Int J Cardiol. 2016;224:447-453.
    PubMed     Text format     Abstract available


  179. SCHMIDT M, Ulrichsen SP, Pedersen L, Botker HE, et al
    30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
    Int J Cardiol. 2016;225:30-36.
    PubMed     Text format     Abstract available


  180. SIMIONIUC A, Carluccio E, Ghio S, Rossi A, et al
    Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients.
    Int J Cardiol. 2016;224:416-423.
    PubMed     Text format     Abstract available


  181. GHOSH RK, Ball S, Prasad V, Gupta A, et al
    Depression in heart failure: Intricate relationship, pathophysiology and most updated evidence of interventions from recent clinical studies.
    Int J Cardiol. 2016;224:170-177.
    PubMed     Text format     Abstract available


  182. TANAKA S, Kamiya K, Masuda T, Hamazaki N, et al
    Low ankle brachial index is associated with the magnitude of impaired walking endurance in patients with heart failure.
    Int J Cardiol. 2016;224:400-405.
    PubMed     Text format     Abstract available


  183. MINAMI Y, Kajimoto K, Sato N, Hagiwara N, et al
    End-stage renal disease patients on chronic maintenance hemodialysis in a hospitalized acute heart failure cohort: Prevalence, clinical characteristics, therapeutic options, and mortality.
    Int J Cardiol. 2016;224:267-270.
    PubMed     Text format    


  184. CHUGH Y, Faillace RT
    The C of CHADS: Historical perspective and clinical applications for anticoagulation in patients with non valvular atrial fibrillation and congestive heart failure.
    Int J Cardiol. 2016;224:431-436.
    PubMed     Text format     Abstract available


  185. VAN DEN BERGE JC, Akkerhuis MK, Constantinescu AA, Kors JA, et al
    Temporal trends in long-term mortality of patients with acute heart failure: Data from 1985-2008.
    Int J Cardiol. 2016;224:456-460.
    PubMed     Text format     Abstract available


  186. CULIC V, Busic Z, Busic M
    Circulating sex hormones, alcohol consumption and echocardiographic parameters of cardiac function in men with heart failure.
    Int J Cardiol. 2016;224:245-251.
    PubMed     Text format    


  187. HOLLINGWORTH W, Biswas M, Maishman RL, Dayer MJ, et al
    The healthcare costs of heart failure during the last five years of life: A retrospective cohort study.
    Int J Cardiol. 2016;224:132-138.
    PubMed     Text format     Abstract available


  188. LAINSCAK M, Vitale C, Seferovic P, Spoletini I, et al
    Pharmacokinetics and pharmacodynamics of cardiovascular drugs in chronic heart failure.
    Int J Cardiol. 2016;224:191-198.
    PubMed     Text format     Abstract available


  189. KAMIYA M, Kamiya M, Tsuzuki M, Tanaka T, et al
    Prevention of re-hospitalization by home-based intervention and adaptive servo-ventilation therapy in a patient who experienced repeated hospitalization for decompensated heart failure.
    Int J Cardiol. 2016;224:96-98.
    PubMed     Text format    


  190. VEGTER EL, Schmitter D, Hagemeijer Y, Ovchinnikova ES, et al
    Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure.
    Int J Cardiol. 2016;224:231-239.
    PubMed     Text format     Abstract available


  191. MASSON S, Barlera S, Colotta F, Magnoli M, et al
    A low plasma 1,25(OH)2 vitamin D/PTH (1-84) ratio predicts worsening of renal function in patients with chronic heart failure.
    Int J Cardiol. 2016;224:220-225.
    PubMed     Text format     Abstract available


  192. PALAZZUOLI A, Testani JM, Ruocco G, Pellegrini M, et al
    Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance.
    Int J Cardiol. 2016;224:213-219.
    PubMed     Text format     Abstract available


  193. HICKEY A, Suna J, Marquart L, Denaro C, et al
    Improving medication titration in heart failure by embedding a structured medication titration plan.
    Int J Cardiol. 2016;224:99-106.
    PubMed     Text format     Abstract available


    August 2016
  194. ARAMBULA-GARZA E, Castillo-Martinez L, Gonzalez-Islas D, Orea-Tejeda A, et al
    Association of cardiac cachexia and atrial fibrillation in heart failure patients.
    Int J Cardiol. 2016;223:863-866.
    PubMed     Text format     Abstract available


  195. GAJANANA D, Shah M, Junpapart P, Romero-Corral A, et al
    Mortality in systolic heart failure revisited: Ischemic versus non-ischemic cardiomyopathy.
    Int J Cardiol. 2016;224:15-17.
    PubMed     Text format    


  196. RUSSO G, Cioffi G, Pulignano G, Barbati G, et al
    Reasons why patients suffering from chronic heart failure at very low risk for mortality die.
    Int J Cardiol. 2016;223:947-952.
    PubMed     Text format     Abstract available


  197. FAYSSOIL A
    Which place for ivabradine in Duchenne muscular dystrophy with heart failure?
    Int J Cardiol. 2016;223:768-769.
    PubMed     Text format    


  198. HUIS IN 'T VELD AE, Van Vliet AG, Spruijt OA, Handoko ML, et al
    CTA-derived left to right atrial size ratio distinguishes between pulmonary hypertension due to heart failure and idiopathic pulmonary arterial hypertension.
    Int J Cardiol. 2016;223:723-728.
    PubMed     Text format     Abstract available


  199. NUNEZ J, Teruel A, Quinones-Torrelo C, Garcia-Blas S, et al
    Continuous ambulatory peritoneal dialysis as a promising therapy for light chain amyloidosis with congestive heart failure.
    Int J Cardiol. 2016;223:807-809.
    PubMed     Text format    


  200. DEMISSEI BG, Postmus D, Liu LC, Cleland JG, et al
    Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial.
    Int J Cardiol. 2016;223:967-975.
    PubMed     Text format     Abstract available


  201. KAWADA T
    Risk of hemodialysis against peritoneal dialysis for chronic heart failure in patients with end-stage renal disease.
    Int J Cardiol. 2016;223:360.
    PubMed     Text format    


  202. BAKIR M, Nelson MD, Jones E, Li Q, et al
    Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation study.
    Int J Cardiol. 2016;223:936-939.
    PubMed     Text format     Abstract available


  203. GIANNINI C, Fiorelli F, Colombo A, De Carlo M, et al
    Right ventricular evaluation to improve survival outcome in patients with severe functional mitral regurgitation and advanced heart failure undergoing MitraClip therapy.
    Int J Cardiol. 2016;223:574-580.
    PubMed     Text format     Abstract available


  204. PRENNER SB, Oskouie S, Shah SJ, Sauer AJ, et al
    Repolarization heterogeneity, diastolic dysfunction, and cardiovascular outcomes in heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;223:116-117.
    PubMed     Text format    


  205. DE BENEDITTIS G, Rosa GD, D'Ettorre E, Piscitelli P, et al
    Effect of Ivabradine in dilated cardiomyopathy from Duchenne muscular dystrophy: A chance for slowing progression of heart failure?
    Int J Cardiol. 2016;223:286-288.
    PubMed     Text format    


  206. OMAR HR, Guglin M
    Characteristics and outcomes of patients with acute systolic heart failure discharged within 48hours: A qualification for "observation status" hospital admission.
    Int J Cardiol. 2016;223:129-132.
    PubMed     Text format    


  207. LINDGREN MP, Smith JG, Li X, Sundquist J, et al
    Sibling risk of hospitalization for heart failure - A nationwide study.
    Int J Cardiol. 2016;223:379-384.
    PubMed     Text format     Abstract available


  208. XING F, Hu X, Jiang J, Ma Y, et al
    A meta-analysis of low-dose dopamine in heart failure.
    Int J Cardiol. 2016;222:1003-1011.
    PubMed     Text format     Abstract available


  209. ZHONG Y, Wang N
    Different etiological factors of heart failure may have diverse levels of biomarkers.
    Int J Cardiol. 2016;223:82.
    PubMed     Text format    


  210. LAL S, Turner L, Powell C, Wilson M, et al
    Improvements in left ventricular ejection fraction and quality of life in patients with heart failure who undergo coronary artery bypass surgery.
    Int J Cardiol. 2016;222:671-673.
    PubMed     Text format    


  211. RUIZ G, Andrey JL, Puerto JL, Escobar MA, et al
    Prognosis of heart failure with preserved ejection fraction treated with beta-blockers: A propensity matched study in the community.
    Int J Cardiol. 2016;222:594-602.
    PubMed     Text format     Abstract available


  212. ROCHA BM, Menezes Falcao L
    Acute decompensated heart failure (ADHF): A comprehensive contemporary review on preventing early readmissions and postdischarge death.
    Int J Cardiol. 2016;223:1035-1044.
    PubMed     Text format     Abstract available


  213. BOJARCZUK J, Josiak K, Kasztura M, Kustrzycka-Kratochwil D, et al
    Iron deficiency in heart failure: Impact on response to cardiac resynchronization therapy.
    Int J Cardiol. 2016;222:133-134.
    PubMed     Text format    


  214. LIN YH, Kuo CC, Lee CM, Chou CH, et al
    5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - a preliminary approach to clinical utility.
    Int J Cardiol. 2016;222:895-900.
    PubMed     Text format     Abstract available


  215. DAMLUJI AA, Macon C, Fox A, Garcia G, et al
    The association between in-hospital hemoglobin changes, cardiovascular events, and mortality in acute decompensated heart failure: Results from the ESCAPE trial.
    Int J Cardiol. 2016;222:531-537.
    PubMed     Text format     Abstract available


  216. REYES EB, Ha JW, Firdaus I, Ghazi AM, et al
    Heart failure across Asia: Same healthcare burden but differences in organization of care.
    Int J Cardiol. 2016;223:163-167.
    PubMed     Text format     Abstract available


    July 2016
  217. HONDA S, Nagai T, Sugano Y, Okada A, et al
    Prevalence, determinants, and prognostic significance of delirium in patients with acute heart failure.
    Int J Cardiol. 2016;222:521-527.
    PubMed     Text format     Abstract available


  218. LEE H, Kim TH, Leem J
    Acupuncture for heart failure: A systematic review of clinical studies.
    Int J Cardiol. 2016;222:321-331.
    PubMed     Text format     Abstract available


  219. LU ML, Davila CD, Shah M, Wheeler DS, et al
    Marital status and living condition as predictors of mortality and readmissions among African Americans with heart failure.
    Int J Cardiol. 2016;222:313-318.
    PubMed     Text format     Abstract available


  220. KAJIMOTO K, Minami Y, Sato N, Takano T, et al
    Serum sodium concentration, blood urea nitrogen, and outcomes in patients hospitalized for acute decompensated heart failure.
    Int J Cardiol. 2016;222:195-201.
    PubMed     Text format     Abstract available


  221. CHEN MC, Chang TH, Chang JP, Huang HD, et al
    Circulating miR-148b-3p and miR-409-3p as biomarkers for heart failure in patients with mitral regurgitation.
    Int J Cardiol. 2016;222:148-154.
    PubMed     Text format     Abstract available


  222. FARMAKIS D, Alvarez J, Gal TB, Brito D, et al
    Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper.
    Int J Cardiol. 2016;222:303-312.
    PubMed     Text format     Abstract available


  223. MARTIN-SANCHEZ FJ, Christ M, Miro O, Peacock WF, et al
    Practical approach on frail older patients attended for acute heart failure.
    Int J Cardiol. 2016;222:62-71.
    PubMed     Text format     Abstract available


  224. BEKFANI T, Pellicori P, Morris DA, Ebner N, et al
    Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life.
    Int J Cardiol. 2016;222:41-46.
    PubMed     Text format     Abstract available


  225. BIELECKA-DABROWA A, Sakowicz A, Misztal M, von Haehling S, et al
    Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies.
    Int J Cardiol. 2016;221:1073-1080.
    PubMed     Text format     Abstract available


  226. CORNELIS J, Beckers P, Taeymans J, Vrints C, et al
    Comparing exercise training modalities in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2016;221:867-876.
    PubMed     Text format     Abstract available


  227. OMAR HR, Guglin M
    Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction.
    Int J Cardiol. 2016;221:1116-1122.
    PubMed     Text format     Abstract available


  228. MADELAIRE C, Schou M, Nelveg-Kristensen KE, Schmiegelow M, et al
    Use of digoxin and risk of death or readmission for heart failure and sinus rhythm: A nationwide propensity score matched study.
    Int J Cardiol. 2016;221:944-950.
    PubMed     Text format     Abstract available


  229. WANG M, Ding H, Kang J, Hu K, et al
    Association between polymorphisms of the HSPB7 gene and Cheyne-Stokes respiration with central sleep apnea in patients with dilated cardiomyopathy and congestive heart failure.
    Int J Cardiol. 2016;221:926-931.
    PubMed     Text format     Abstract available


  230. LAOUTARIS ID, Adamopoulos S, Manginas A, Panagiotakos DB, et al
    Inspiratory work capacity is more severely depressed than inspiratory muscle strength in patients with heart failure: Novel applications for inspiratory muscle training.
    Int J Cardiol. 2016;221:622-626.
    PubMed     Text format     Abstract available


  231. EGUCHI A, Iwasaku T, Okuhara Y, Naito Y, et al
    Long-term administration of tolvaptan increases myocardial remodeling and mortality via exacerbation of congestion in mice heart failure model after myocardial infarction.
    Int J Cardiol. 2016;221:302-309.
    PubMed     Text format     Abstract available


  232. HUYNH QL, Negishi K, Blizzard L, Saito M, et al
    Mild cognitive impairment predicts death and readmission within 30days of discharge for heart failure.
    Int J Cardiol. 2016;221:212-217.
    PubMed     Text format     Abstract available


  233. AUFFRET V, Leurent G, Gilard M, Hacot JP, et al
    Incidence, timing, predictors and impact of acute heart failure complicating ST-segment elevation myocardial infarction in patients treated by primary percutaneous coronary intervention.
    Int J Cardiol. 2016;221:433-442.
    PubMed     Text format     Abstract available


  234. DOMINGUEZ-RODRIGUEZ A, Abreu-Gonzalez P, Piccolo R, Galasso G, et al
    Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony.
    Int J Cardiol. 2016;221:359-363.
    PubMed     Text format     Abstract available


  235. BHATT KN, Kalogeropoulos AP, Dunbar SB, Butler J, et al
    Depression in heart failure: Can PHQ-9 help?
    Int J Cardiol. 2016;221:246-250.
    PubMed     Text format     Abstract available


  236. AREVALO-LORIDO JC, Gomez JC, Formiga F, Conde-Martel A, et al
    High serum osmolarity at admission determines a worse outcome in patients with heart failure: Is a new target emerging?
    Int J Cardiol. 2016;221:238-242.
    PubMed     Text format     Abstract available


  237. MATSUE Y, Suzuki M, Torii S, Yamaguchi S, et al
    Prognostic impact of early treatment with tolvaptan in patients with acute heart failure and renal dysfunction.
    Int J Cardiol. 2016;221:188-193.
    PubMed     Text format     Abstract available


  238. BANERJEE P, Motiwala A, Mustafa HM, Gani MA, et al
    Does left ventricular diastolic dysfunction progress through stages? Insights from a community heart failure study.
    Int J Cardiol. 2016;221:850-854.
    PubMed     Text format     Abstract available


  239. TROMP J, Meyer S, Mentz RJ, O'Connor CM, et al
    Acute heart failure in the young: Clinical characteristics and biomarker profiles.
    Int J Cardiol. 2016;221:1067-1072.
    PubMed     Text format     Abstract available


  240. JEWISS D, Ostman C, Smart NA
    The effect of resistance training on clinical outcomes in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2016;221:674-681.
    PubMed     Text format     Abstract available


  241. GUIZONI DM, Oliveira-Junior SA, Noor SL, Pagan LU, et al
    Effects of late exercise on cardiac remodeling and myocardial calcium handling proteins in rats with moderate and large size myocardial infarction.
    Int J Cardiol. 2016;221:406-412.
    PubMed     Text format     Abstract available


  242. BANFI C, Agostoni P
    Surfactant protein B: From biochemistry to its potential role as diagnostic and prognostic marker in heart failure.
    Int J Cardiol. 2016;221:456-462.
    PubMed     Text format     Abstract available


  243. PERCIACCANTE A, Coralli A, Bianucci R
    Has Saint Anthony of Padua suffered from congestive heart failure?
    Int J Cardiol. 2016;221:110-111.
    PubMed     Text format    


  244. AMIR O, Azzam ZS, Gaspar T, Faranesh-Abboud S, et al
    Validation of remote dielectric sensing (ReDS) technology for quantification of lung fluid status: Comparison to high resolution chest computed tomography in patients with and without acute heart failure.
    Int J Cardiol. 2016;221:841-846.
    PubMed     Text format     Abstract available


  245. SAIRAKU A, Yoshida Y, Nakano Y, Hirayama H, et al
    Don't expect left ventricular reverse remodeling after cardiac resynchronization therapy in patients with systolic heart failure and atrioventricular block: A multicenter study.
    Int J Cardiol. 2016;221:597-600.
    PubMed     Text format     Abstract available


    June 2016
  246. CEBRIAN-CUENCA AM, Orozco-Beltran D, Navarro-Perez J, Franch-Nadal J, et al
    Saxagliptin and risk of heart failure hospitalization: Concern or miscalculation?
    Int J Cardiol. 2016;220:573-574.
    PubMed     Text format    


  247. CORNELIS J, Vrints C, Vanroy C, Vissers D, et al
    Letter by Cornelis et al. regarding article, "Exercise oscillatory ventilation in heart failure".
    Int J Cardiol. 2016;220:759-760.
    PubMed     Text format    


  248. MAKUBI A, Hage C, Sartipy U, Lwakatare J, et al
    Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF).
    Int J Cardiol. 2016;220:750-758.
    PubMed     Text format     Abstract available


  249. VAZIR A, Simpkin VL, Marino P, Ludman A, et al
    Association of haemodynamic changes measured by serial central venous saturation during ultrafiltration for acutely decompensated heart failure with diuretic resistance and change in renal function.
    Int J Cardiol. 2016;220:618-622.
    PubMed     Text format     Abstract available


  250. EDWARDS MK, Loprinzi PD
    Sedentary behavior & health-related quality of life among congestive heart failure patients.
    Int J Cardiol. 2016;220:520-523.
    PubMed     Text format     Abstract available


  251. PIOTROWICZ E, Piepoli MF, Jaarsma T, Lambrinou E, et al
    Telerehabilitation in heart failure patients: The evidence and the pitfalls.
    Int J Cardiol. 2016;220:408-413.
    PubMed     Text format     Abstract available


  252. PARK SY, Trinity JD, Gifford JR, Diakos NA, et al
    Mitochondrial function in heart failure: The impact of ischemic and non-ischemic etiology.
    Int J Cardiol. 2016;220:711-717.
    PubMed     Text format     Abstract available


  253. NUNEZ J, Nunez E, Minana G, Carratala A, et al
    Serum neprilysin and recurrent hospitalizations after acute heart failure.
    Int J Cardiol. 2016;220:742-744.
    PubMed     Text format    


  254. ZWISLER AD, Norton RJ, Dean SG, Dalal H, et al
    Home-based cardiac rehabilitation for people with heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2016;221:963-969.
    PubMed     Text format     Abstract available


  255. FURIHATA T, Kinugawa S, Fukushima A, Takada S, et al
    Serum myostatin levels are independently associated with skeletal muscle wasting in patients with heart failure.
    Int J Cardiol. 2016;220:483-487.
    PubMed     Text format     Abstract available


  256. SINIORAKIS EE, Arapi SM, Panta SG, Pyrgakis VN, et al
    Emergency department triage of acute heart failure triggered by pneumonia; when an intensive care unit is needed?
    Int J Cardiol. 2016;220:479-482.
    PubMed     Text format     Abstract available


  257. MOREIRA-SILVA S, Urbano J, Moura MC, Ferreira-Coimbra J, et al
    Liver cytolysis in acute heart failure: What does it mean? Clinical profile and outcomes of a prospective hospital cohort.
    Int J Cardiol. 2016;221:422-427.
    PubMed     Text format     Abstract available


  258. KATZ A, Maor E, Leor J, Klempfner R, et al
    Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure.
    Int J Cardiol. 2016;221:198-204.
    PubMed     Text format     Abstract available


  259. OMAR HR, Guglin M
    Longitudinal BNP follow-up as a marker of treatment response in acute heart failure: Relationship with objective markers of decongestion.
    Int J Cardiol. 2016;221:167-170.
    PubMed     Text format     Abstract available


  260. OZAWA K, Funabashi N, Sugiura A, Kobayashi Y, et al
    Layer specific strain measurement and its relationship to heart failure indicators in systemic autoimmune disorder patients: A multi-layer transthoracic echocardiography study.
    Int J Cardiol. 2016;220:693-699.
    PubMed     Text format    


  261. DENG J, Zhong Q
    Advanced research on the microRNA mechanism in heart failure.
    Int J Cardiol. 2016;220:61-64.
    PubMed     Text format     Abstract available


  262. GU J, Fan YQ, Han ZH, Fan L, et al
    Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients.
    Int J Cardiol. 2016;220:56-60.
    PubMed     Text format     Abstract available


  263. PAN WQ, He YH, Su Q, Yang J, et al
    Association of decreased serum vasostatin-2 level with ischemic chronic heart failure and with MACE in 3-year follow-up: Vasostatin-2 prevents heart failure in myocardial infarction rats.
    Int J Cardiol. 2016;221:1-11.
    PubMed     Text format     Abstract available


  264. OMAR HR, Guglin M
    Hypothermia is an independent predictor of short and intermediate term mortality in acute systolic heart failure: Insights from the ESCAPE trial.
    Int J Cardiol. 2016;220:729-733.
    PubMed     Text format     Abstract available


  265. CHANG CH, Chang YC, Lin JW, Caffrey JL, et al
    No increased risk of hospitalization for heart failure for patients treated with dipeptidyl peptidase-4 inhibitors in Taiwan.
    Int J Cardiol. 2016;220:14-20.
    PubMed     Text format     Abstract available


  266. BERTON G, Cordiano R, Cavuto F, Bagato F, et al
    Heart failure in women and men during acute coronary syndrome and long-term cardiovascular mortality (the ABC-3* Study on Heart Disease) (*Adria, Bassano, Conegliano, and Padova Hospitals).
    Int J Cardiol. 2016;220:538-543.
    PubMed     Text format     Abstract available


  267. SOKORELI I, de Vries JJ, Riistama JM, Pauws SC, et al
    Depression as an independent prognostic factor for all-cause mortality after a hospital admission for worsening heart failure.
    Int J Cardiol. 2016;220:202-207.
    PubMed     Text format     Abstract available


  268. FARMAKIS D, Filippatos G, Parissis J, Karavidas A, et al
    Structured discharge instructions for hospitalized heart failure patients to improve guideline implementation and patient outcomes.
    Int J Cardiol. 2016;220:143-145.
    PubMed     Text format    


  269. RUIGOMEZ A, Michel A, Martin-Perez M, Garcia Rodriguez LA, et al
    Heart failure hospitalization: An important prognostic factor for heart failure re-admission and mortality.
    Int J Cardiol. 2016;220:855-861.
    PubMed     Text format     Abstract available


  270. ERTEKIN E, van Hagen IM, Salam AM, Ruys TP, et al
    Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology.
    Int J Cardiol. 2016;220:131-136.
    PubMed     Text format     Abstract available


  271. RAFFA GM, Di Gesaro G, Sciacca S, Tuzzolino F, et al
    Heart transplant program at IRCCS-ISMETT: Impact of mechanical circulatory support on pre- and post -transplant survival.
    Int J Cardiol. 2016;219:358-361.
    PubMed     Text format     Abstract available


  272. SALAMANCA-BAUTISTA P, Conde-Martel A, Aramburu-Bodas O, Formiga F, et al
    Precipitating factors of heart failure admission: Differences related to age and left ventricular ejection fraction.
    Int J Cardiol. 2016;219:150-155.
    PubMed     Text format     Abstract available


  273. ORSZULAK M, Mizia-Stec K, Siennicka A, Goscinska-Bis K, et al
    Differences of psychological features in patients with heart failure with regard to gender and aetiology - Results of a CAPS-LOCK-HF (Complex Assessment of Psychological Status Located in Heart Failure) study.
    Int J Cardiol. 2016;219:380-386.
    PubMed     Text format     Abstract available


  274. MARCINKIEWICZ-SIEMION M, Ciborowski M, Kretowski A, Musial WJ, et al
    Metabolomics - A wide-open door to personalized treatment in chronic heart failure?
    Int J Cardiol. 2016;219:156-163.
    PubMed     Text format     Abstract available


  275. ZUPAN MEZNAR A, Berden P, Lainscak M
    Left ventricular metastasis of soft tissue sarcoma causing heart failure: Presentation of two cases.
    Int J Cardiol. 2016;219:119-120.
    PubMed     Text format    


  276. WANG S, Liu M, Fang F, Shang Q, et al
    Prognostic value of acoustic cardiography in patients with chronic heart failure.
    Int J Cardiol. 2016;219:121-126.
    PubMed     Text format     Abstract available


    May 2016
  277. D'ONOFRIO A, Iuliano A, De Simone A, Pecora D, et al
    Electrical remodeling after cardiac resynchronization therapy and its relationship with the anatomical remodeling.
    Int J Cardiol. 2016;211:86-7.
    PubMed     Text format    


  278. NIEMINEN MS, Buerke M, Cohen-Solal A, Costa S, et al
    The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion.
    Int J Cardiol. 2016;218:150-157.
    PubMed     Text format     Abstract available


  279. BAUM C, Ojeda FM, Wild PS, Rzayeva N, et al
    Subclinical impairment of lung function is related to mild cardiac dysfunction and manifest heart failure in the general population.
    Int J Cardiol. 2016;218:298-304.
    PubMed     Text format     Abstract available


  280. KUBE J, Ebner N, Jankowska EA, Rozentryt P, et al
    The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.
    Int J Cardiol. 2016;219:84-91.
    PubMed     Text format     Abstract available


  281. GEORGIOPOULOU VV, Tang WH, Giamouzis G, Li S, et al
    Renal biomarkers and outcomes in outpatients with heart failure: The Atlanta cardiomyopathy consortium.
    Int J Cardiol. 2016;218:136-143.
    PubMed     Text format     Abstract available


  282. OMAR HR, Guglin M
    Extremely elevated BNP in acute heart failure: Patient characteristics and outcomes.
    Int J Cardiol. 2016;218:120-125.
    PubMed     Text format     Abstract available


  283. COGLIATI C, Casazza G, Ceriani E, Torzillo D, et al
    Lung ultrasound and short-term prognosis in heart failure patients.
    Int J Cardiol. 2016;218:104-108.
    PubMed     Text format     Abstract available


  284. AL-KINDI SG, ElAmm C, Ginwalla M, Mehanna E, et al
    Heart failure in patients with human immunodeficiency virus infection: Epidemiology and management disparities.
    Int J Cardiol. 2016;218:43-46.
    PubMed     Text format     Abstract available


  285. DE ANGELIS A, Cappetta D, Piegari E, Rinaldi B, et al
    Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;217:69-79.
    PubMed     Text format     Abstract available


  286. KANG J, Park J, Lee JM, Park JJ, et al
    The effects of erythropoiesis stimulating therapy for anemia in chronic heart failure: A meta-analysis of randomized clinical trials.
    Int J Cardiol. 2016;218:12-22.
    PubMed     Text format     Abstract available


  287. VOLTERRANI M, Iellamo F, Senni M, Piepoli MF, et al
    Therapeutic options of Angiotensin Receptor Neprilysin inhibitors (ARNis) in chronic heart failure with reduced ejection fraction: Beyond RAAS and sympathetic nervous system inhibition.
    Int J Cardiol. 2016 May 7. pii: S0167-5273(16)30876.
    PubMed     Text format     Abstract available


  288. VAN RIET EE, Hoes AW, Limburg A, Landman MA, et al
    Effect of training general practitioners in drug treatment of newly detected heart failure patients with reduced or preserved ejection fraction: A cluster randomized trial.
    Int J Cardiol. 2016;217:174-182.
    PubMed     Text format     Abstract available


  289. RIM TH, Oh J, Kang SM, Kim SS, et al
    Association between retinal vein occlusion and risk of heart failure: A 12-year nationwide cohort study.
    Int J Cardiol. 2016;217:122-127.
    PubMed     Text format     Abstract available


    April 2016
  290. RICCI F, Di Castelnuovo A, Savarese G, Perrone Filardi P, et al
    ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis.
    Int J Cardiol. 2016;217:128-134.
    PubMed     Text format     Abstract available


  291. BOSSEAU C, Donal E
    Conflicting and unresolved issue of the prognostic value of atrial fibrillation for chronic heart failure patients.
    Int J Cardiol. 2016 Apr 22. pii: S0167-5273(16)30278.
    PubMed     Text format    


  292. KOULAOUZIDIS G, Iakovidis DK, Clark AL
    Telemonitoring predicts in advance heart failure admissions.
    Int J Cardiol. 2016;216:78-84.
    PubMed     Text format     Abstract available


  293. HIDALGO FJ, Anguita M, Castillo JC, Rodriguez S, et al
    Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study.
    Int J Cardiol. 2016;217:7-11.
    PubMed     Text format     Abstract available


  294. ONOUE Y, Izumiya Y, Hanatani S, Tanaka T, et al
    A simple sarcopenia screening test predicts future adverse events in patients with heart failure.
    Int J Cardiol. 2016;215:301-306.
    PubMed     Text format     Abstract available


  295. KINOSHITA K, Kawai M, Minai K, Ogawa K, et al
    Potent influence of obesity on suppression of plasma B-type natriuretic peptide levels in patients with acute heart failure: An approach using covariance structure analysis.
    Int J Cardiol. 2016;215:283-290.
    PubMed     Text format     Abstract available


  296. CARROLL R, Mudge A, Suna J, Denaro C, et al
    Prescribing and up-titration in recently hospitalized heart failure patients attending a disease management program.
    Int J Cardiol. 2016;216:121-127.
    PubMed     Text format     Abstract available


  297. DAMATTO RL, Lima AR, Martinez PF, Cezar MD, et al
    Myocardial myostatin in spontaneously hypertensive rats with heart failure.
    Int J Cardiol. 2016;215:384-387.
    PubMed     Text format     Abstract available


  298. KLOPPE A, Lawo T, Mijic D, Schiedat F, et al
    Long-term survival with Cardiac Contractility Modulation in patients with NYHA II or III symptoms and normal QRS duration.
    Int J Cardiol. 2016;209:291-5.
    PubMed     Text format     Abstract available


  299. CANDEL FJ, Matesanz M, Martin-Sanchez FJ, Gonzalez Del Castillo JM, et al
    Monitoring of high-dose fosfomycin guided by NT-proBNP.
    Int J Cardiol. 2016;209:131-2.
    PubMed     Text format    


  300. POURAFKARI L, Wang CK, Schwartz M, Nader ND, et al
    Does shock index provide prognostic information in acute heart failure?
    Int J Cardiol. 2016;215:140-142.
    PubMed     Text format    


  301. SHIRAISHI M, Murakami T, Nawa T, Kobayashi H, et al
    Hypertonic saline with furosemide for diuretic resistant congestive heart failure in an infant.
    Int J Cardiol. 2016;215:127-128.
    PubMed     Text format    


  302. KIVIKKO M, Pollesello P, Tarvasmaki T, Sarapohja T, et al
    Effect of baseline characteristics on mortality in the SURVIVE trial on the effect of levosimendan vs dobutamine in acute heart failure: Sub-analysis of the Finnish patients.
    Int J Cardiol. 2016;215:26-31.
    PubMed     Text format     Abstract available


  303. BRISCO MA, Zile MR, Ter Maaten JM, Hanberg JS, et al
    The risk of death associated with proteinuria in heart failure is restricted to patients with an elevated blood urea nitrogen to creatinine ratio.
    Int J Cardiol. 2016;215:521-526.
    PubMed     Text format     Abstract available


  304. VIEIRA JL, Guimaraes GV, de Andre PA, Saldiva PH, et al
    Effects of reducing exposure to air pollution on submaximal cardiopulmonary test in patients with heart failure: Analysis of the randomized, double-blind and controlled FILTER-HF trial.
    Int J Cardiol. 2016;215:92-97.
    PubMed     Text format     Abstract available


  305. GASTELURRUTIA P, Cuba-Gyllensten I, Lupon J, Zamora E, et al
    Wearable vest for pulmonary congestion tracking and prognosis in heart failure: A pilot study.
    Int J Cardiol. 2016;215:77-79.
    PubMed     Text format    


  306. SLAWUTA A, Mazur G, Malecka B, Gajek J, et al
    Permanent His bundle pacing - An optimal treatment method in heart failure patients with AF and narrow QRS.
    Int J Cardiol. 2016;214:451-452.
    PubMed     Text format    


  307. FENG YX, Yang LJ, Li T, Dong HW, et al
    Association between elevated D-dimer levels and adverse outcome in patients with acute heart failure.
    Int J Cardiol. 2016;214:415-416.
    PubMed     Text format    


  308. WANG J, Hu X, Jiang H
    MSCs modified with HO-1 gene transplantation: A novel therapeutic approach for attenuating heart failure.
    Int J Cardiol. 2016;214:159-160.
    PubMed     Text format    


  309. FUKUTA H, Goto T, Wakami K, Ohte N, et al
    The effect of statins on mortality in heart failure with preserved ejection fraction: a meta-analysis of propensity score analyses.
    Int J Cardiol. 2016;214:301-306.
    PubMed     Text format     Abstract available


  310. SMITH S, Rossignol P, Willis S, Zannad F, et al
    Neural modulation for hypertension and heart failure.
    Int J Cardiol. 2016;214:320-330.
    PubMed     Text format     Abstract available


  311. LOMBARDI C, Fanfulla F, Parati G
    Treatment of central sleep apnea in heart failure patients: Benefit or harm?
    Int J Cardiol. 2016;214:254-255.
    PubMed     Text format    


  312. ZIAEI F, Zaman M, Rasoul D, Gorantla RS, et al
    The prevalence of atrial fibrillation amongst heart failure patients increases with age.
    Int J Cardiol. 2016;214:410-411.
    PubMed     Text format    


    March 2016
  313. WANG J, Hu X, Jiang H
    HDAC inhibition: A novel therapeutic approach for attenuating heart failure by suppressing cardiac remodeling.
    Int J Cardiol. 2016;214:41-42.
    PubMed     Text format    


  314. LOPRINZI PD
    Physical activity, weight status, and mortality among congestive heart failure patients.
    Int J Cardiol. 2016;214:92-94.
    PubMed     Text format     Abstract available


  315. MINANA G, Rumiz E, Palau P, Valero E, et al
    Plasma neutrophil gelatinase-associated lipocalin and long-term mortality in patients with acute heart failure and normal renal function.
    Int J Cardiol. 2016;214:51-53.
    PubMed     Text format    


  316. KOTECHA D
    Letter: Conflicting and unresolved issue of the prognostic value of atrial fibrillation for chronic heart failure patients - Response.
    Int J Cardiol. 2016 Mar 25. pii: S0167-5273(16)30529.
    PubMed     Text format    


  317. OH PC, Koh KK
    Recurrent stress-induced cardiomyopathy presented with acute decompensated heart failure.
    Int J Cardiol. 2016;212:307-309.
    PubMed     Text format    


  318. GUO WQ, Li L
    Angiotensin converting enzyme inhibitors for heart failure with reduced ejection fraction or left ventricular dysfunction: A complementary network meta-analyses.
    Int J Cardiol. 2016;214:10-12.
    PubMed     Text format    


  319. NEGRI F, Gamba A, Belgrano M, Bussani R, et al
    Hypertrophic Cardiomyopathy: An unexpected finding in a surgical variant of Heterotopic Heart Transplantation.
    Int J Cardiol. 2016;214:121-122.
    PubMed     Text format    


  320. ROSSI F, Mascolo A, Mollace V
    The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure.
    Int J Cardiol. 2016 Mar 23. pii: S0167-5273(16)30502.
    PubMed     Text format     Abstract available


  321. RADULOVIC B, Potocnjak I, Dokoza Teresak S, Trbusic M, et al
    Hypochloraemia as a predictor of developing hyponatraemia and poor outcome in acute heart failure patients.
    Int J Cardiol. 2016;212:237-241.
    PubMed     Text format     Abstract available


  322. BACURAU AV, Jannig PR, de Moraes WM, Cunha TF, et al
    Akt/mTOR pathway contributes to skeletal muscle anti-atrophic effect of aerobic exercise training in heart failure mice.
    Int J Cardiol. 2016;214:137-147.
    PubMed     Text format     Abstract available


  323. OHUCHI H, Hayama Y, Negishi J, Noritake K, et al
    Heart failure with preserved right ventricular ejection fraction in postoperative adults with congenital heart disease: A subtype of severe right ventricular pathophysiology.
    Int J Cardiol. 2016;212:223-231.
    PubMed     Text format     Abstract available


  324. KUNDU A, Sardar P, Ghosh S, Patel P, et al
    Risk of heart failure with dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2016;212:203-205.
    PubMed     Text format    


  325. KAJIMOTO K, Sato N, Takano T
    Association between age, time after hospitalization, and survival among patients hospitalized for acute heart failure syndromes.
    Int J Cardiol. 2016;212:151-153.
    PubMed     Text format    


  326. LOPRINZI PD
    Physical activity with alanine aminotransferase and gamma-glutamyltransferase among congestive heart failure patients.
    Int J Cardiol. 2016;212:61-62.
    PubMed     Text format    


  327. DURMAZ O, Olgun Kucuk H, Kucuk U
    Intricate associations between heart failure, depression and vitamin D.
    Int J Cardiol. 2016;212:121.
    PubMed     Text format    


  328. SU JL, Zhang SG, Gao RJ, Han QF, et al
    Red cell distribution width is a predictor of mortality in patients with chronic heart failure.
    Int J Cardiol. 2016;212:79-81.
    PubMed     Text format    


  329. YI X, Li X, Jiang X
    Carabin: Endogenous calcineurin inhibitor, a potential diagnostic and therapeutic target for cardiac hypertrophy in heart failure.
    Int J Cardiol. 2016;212:57-58.
    PubMed     Text format    


  330. ELEUTERI E, Di Stefano A, Giordano A, Corra U, et al
    Prognostic value of angiopoietin-2 in patients with chronic heart failure.
    Int J Cardiol. 2016;212:364-368.
    PubMed     Text format     Abstract available


  331. YOSHIHISA A, Suzuki S, Kanno Y, Takiguchi M, et al
    Prognostic significance of periodic leg movements during sleep in heart failure patients.
    Int J Cardiol. 2016;212:11-13.
    PubMed     Text format    


  332. LOPRINZI PD
    Implications of light-intensity physical activity in improving health-related quality of life among congestive heart failure patients.
    Int J Cardiol. 2016;212:16-17.
    PubMed     Text format    


  333. STEWART S, Riegel B, Boyd C, Ahamed Y, et al
    Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement.
    Int J Cardiol. 2016;212:1-10.
    PubMed     Text format     Abstract available


  334. JONSSON A, Hallberg AC, Edner M, Lund LH, et al
    A comprehensive assessment of the association between anemia, clinical covariates and outcomes in a population-wide heart failure registry.
    Int J Cardiol. 2016;211:124-131.
    PubMed     Text format    


  335. GANGA HV, Jantz J, Puppala VK
    The impact of iron deficiency on exercise capacity in chronic heart failure patients.
    Int J Cardiol. 2016 Mar 2. pii: S0167-5273(16)30122.
    PubMed     Text format    


  336. PARENICA J, Kala P, Pavkova MG, Tomandl J, et al
    Natriuretic peptides, nitrite/nitrate and superoxide dismutase have additional value on top of the GRACE score in prediction of one-year mortality and rehospitalisation for heart failure in STEMI patients - Multiple biomarkers prospective cohort study
    Int J Cardiol. 2016;211:96-104.
    PubMed     Text format     Abstract available


  337. KONGWATCHARAPONG J, Dilokthornsakul P, Nathisuwan S, Phrommintikul A, et al
    Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials.
    Int J Cardiol. 2016;211:88-95.
    PubMed     Text format     Abstract available


  338. BOONMAN-DE WINTER LJ, van Stel HF, Hoes AW, Landman MJ, et al
    Health status of older patients with type 2 diabetes and screen-detected heart failure is significantly lower than those without.
    Int J Cardiol. 2016;211:79-83.
    PubMed     Text format    


  339. LEE JF, Barrett-O'Keefe Z, Nelson AD, Garten RS, et al
    Impaired skeletal muscle vasodilation during exercise in heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;211:14-21.
    PubMed     Text format     Abstract available


  340. LAINSCAK M, Coats AJ
    The PARADIGM of ARNI's: Assessing reasons for non-implementation in heart failure.
    Int J Cardiol. 2016;212:187-189.
    PubMed     Text format     Abstract available


  341. JOSEPH S, Costanzo MR
    A novel therapeutic approach for central sleep apnea: Phrenic nerve stimulation by the remede(R) System.
    Int J Cardiol. 2016;206 Suppl:S28-34.
    PubMed     Text format     Abstract available


  342. FLINTA I, Ponikowski P
    Relationship between central sleep apnea and Cheyne-Stokes Respiration.
    Int J Cardiol. 2016;206 Suppl:S8-12.
    PubMed     Text format     Abstract available


  343. KHAYAT RN, Abraham WT
    Current treatment approaches and trials in central sleep apnea.
    Int J Cardiol. 2016;206 Suppl:S22-7.
    PubMed     Text format     Abstract available


    February 2016
  344. NAUGHTON MT
    Epidemiology of central sleep apnoea in heart failure.
    Int J Cardiol. 2016 Feb 26. pii: S0167-5273(16)30359.
    PubMed     Text format     Abstract available


  345. COATS AJ, Shewan LG
    Measuring therapeutic efficacy in the treatment of CSA in patients with heart failure.
    Int J Cardiol. 2016 Feb 24. pii: S0167-5273(16)30356.
    PubMed     Text format     Abstract available


  346. COATS AJ, Abraham WT
    Central sleep apnoea in heart failure - An important issue for the modern heart failure cardiologist.
    Int J Cardiol. 2016 Feb 24. pii: S0167-5273(16)30353.
    PubMed     Text format    


  347. CORRA U
    Exercise oscillatory ventilation in heart failure.
    Int J Cardiol. 2016 Feb 23. pii: S0167-5273(16)30355.
    PubMed     Text format     Abstract available


  348. VASSILIOU VS, Patel HC, Rosen SD, Auger D, et al
    Left atrial dilation in patients with heart failure and preserved ejection fraction: Insights from cardiovascular magnetic resonance.
    Int J Cardiol. 2016;210:158-160.
    PubMed     Text format    


  349. KOUNIS NG, Soufras GD, Lianas D, Patsouras N, et al
    Heparin-induced thrombocytopenia, allergy to heparins, heart failure, thrombi, and the Kounis syndrome.
    Int J Cardiol. 2016 Feb 20. pii: S0167-5273(16)30340.
    PubMed     Text format    


  350. TANAKA A, Nakamura T, Sato E, Node K, et al
    Aquaporin-2 is a potential biomarker for tolvaptan efficacy in decompensated heart failure complicated by diabetic nephrotic syndrome.
    Int J Cardiol. 2016;210:1-3.
    PubMed     Text format    


  351. CHATTERJEE NA, Singh JP, Szymonifka J, Deano RC, et al
    Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study.
    Int J Cardiol. 2016;205:43-9.
    PubMed     Text format     Abstract available


  352. ABDUL-RAHIM AH, MacIsaac RL, Jhund PS, Petrie MC, et al
    Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial.
    Int J Cardiol. 2016;209:310-316.
    PubMed     Text format     Abstract available


  353. KONDO M, Kohno T, Kohsaka S, Fukuoka R, et al
    Enhanced oxidative stress is associated with sleep-disordered breathing and obesity in patients with heart failure.
    Int J Cardiol. 2016;209:133-135.
    PubMed     Text format    


  354. MARRA AM, Arcopinto M, Salzano A, Bobbio E, et al
    Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure.
    Int J Cardiol. 2016;209:114-117.
    PubMed     Text format    


  355. KAWADA T
    Antidepressant use, clinical depression and mortality in patients with heart failure.
    Int J Cardiol. 2016;209:68-69.
    PubMed     Text format    


  356. MELGAARD L, Gorst-Rasmussen A, Sogaard P, Rasmussen LH, et al
    Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation.
    Int J Cardiol. 2016;209:1-6.
    PubMed     Text format     Abstract available


  357. ARMENI P, Boscolo PR, Tarricone R, Capodanno D, et al
    Real-world cost effectiveness of MitraClip combined with Medical Therapy Versus Medical therapy alone in patients with moderate or severe mitral regurgitation.
    Int J Cardiol. 2016;209:153-160.
    PubMed     Text format     Abstract available


  358. MENET A, Guyomar Y, Ennezat PV, Graux P, et al
    Prognostic value of left ventricular reverse remodeling and performance improvement after cardiac resynchronization therapy: A prospective study.
    Int J Cardiol. 2016;204:6-11.
    PubMed     Text format     Abstract available


    January 2016
  359. VROMEN T, Kraal JJ, Kuiper J, Spee RF, et al
    The influence of training characteristics on the effect of aerobic exercise training in patients with chronic heart failure: A meta-regression analysis.
    Int J Cardiol. 2016;208:120-127.
    PubMed     Text format     Abstract available


  360. KAWADA T
    Survival risk of salivary cortisol and serum N-terminal pro-hormone B-type natriuretic peptide in patients with systolic heart failure.
    Int J Cardiol. 2016 Jan 25. pii: S0167-5273(16)30193.
    PubMed     Text format    


  361. BEHNES M, Bertsch T, Weiss C, Ahmad-Nejad P, et al
    Response to letter: Device therapy and aldosterone antagonists in the prognosis of heart failure.
    Int J Cardiol. 2016 Jan 21. pii: S0167-5273(16)30198.
    PubMed     Text format    


  362. POLLESELLO P, Papp Z, Papp JG
    Calcium sensitizers: What have we learned over the last 25 years?
    Int J Cardiol. 2016;203:543-8.
    PubMed     Text format     Abstract available


  363. HUANG Y, Mai L, Cai X, Hu Y, et al
    Stem cell therapy for heart disease-Meta-analysis may be misleading.
    Int J Cardiol. 2016;203:351-2.
    PubMed     Text format    


  364. KITADA S, Schulze PC, Jin Z, Clerkin KJ, et al
    Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset.
    Int J Cardiol. 2016;203:929-35.
    PubMed     Text format     Abstract available


  365. SINNING C, Kozlik-Feldmann R, Demir C, Blankenberg S, et al
    Long-term course of a patient with congenital corrected transposition of the great arteries and dextrocardia--The Fisher King.
    Int J Cardiol. 2016;203:436-7.
    PubMed     Text format    


  366. TSCHOPE C, Van Linthout S, Spillmann F, Klein O, et al
    Cardiac contractility modulation signals improve exercise intolerance and maladaptive regulation of cardiac key proteins for systolic and diastolic function in HFpEF.
    Int J Cardiol. 2016;203:1061-6.
    PubMed     Text format    


  367. FUNG E, Fong MW, Correa AJ, Yoon AJ, et al
    Fulminant eosinophilic myocarditis following ICD implantation in a patient with undisclosed nickel allergy.
    Int J Cardiol. 2016;203:1018-9.
    PubMed     Text format    


  368. MADIAS JE
    Takotsubo syndrome/QTc interval prolongation/myocardial edema/cardiac sympathetic denervation/cardiac arrhythmias: A quintet needing exploration.
    Int J Cardiol. 2016;203:259-61.
    PubMed     Text format    


  369. NUNEZ J, Dominguez E, Ramon JM, Nunez E, et al
    Iron deficiency and functional capacity in patients with advanced heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;207:365-367.
    PubMed     Text format    


  370. PIPER SE, de Courcey J, Sherwood RA, Amin-Youssef GF, et al
    Serial galectin-3 for the monitoring of optimally treated stable chronic heart failure: A pilot study.
    Int J Cardiol. 2016;207:279-281.
    PubMed     Text format    


  371. MUNOZ MA, Real J, Del Val JL, Vinyoles E, et al
    Determinants of survival and hospitalization in older, heart failure patients receiving home healthcare.
    Int J Cardiol. 2016;207:145-149.
    PubMed     Text format     Abstract available


  372. JOHANSSON P, Alehagen U, van der Wal MH, Svensson E, et al
    Vitamin D levels and depressive symptoms in patients with chronic heart failure.
    Int J Cardiol. 2016;207:185-189.
    PubMed     Text format     Abstract available


  373. ONO R, Funabashi N, Takaoka H, Ozawa K, et al
    Massive myocardial aneurysm due to inferior to posterior myocardial infarction complicated with right-sided heart failure in a 36-year-old male.
    Int J Cardiol. 2016;209:98-102.
    PubMed     Text format    


  374. MICHEL A, Martin-Perez M, Ruigomez A, Garcia Rodriguez LA, et al
    Incidence and risk factors for severe renal impairment after first diagnosis of heart failure: A cohort and nested case-control study in UK general practice.
    Int J Cardiol. 2016;207:252-257.
    PubMed     Text format     Abstract available


  375. LOPRINZI PD
    Physical activity and peripheral arterial disease among patients with coronary artery disease or congestive heart failure.
    Int J Cardiol. 2016;207:110-111.
    PubMed     Text format    


  376. CURCIO A, Cascini GL, De Rosa S, Pasceri E, et al
    I-mIBG imaging predicts functional improvement and clinical outcome in patients with heart failure and CRT implantation.
    Int J Cardiol. 2016;207:107-109.
    PubMed     Text format    


  377. ALHAJ EK
    Can unilateral adrenalectomy be an option in modulating autonomic nervous system in heart failure?
    Int J Cardiol. 2016;207:50-52.
    PubMed     Text format     Abstract available


  378. CARTER P, Reynolds J, Carter A, Potluri S, et al
    The impact of psychiatric comorbidities on the length of hospital stay in patients with heart failure.
    Int J Cardiol. 2016;207:292-296.
    PubMed     Text format     Abstract available


  379. DIXON DL, Bersten AD, Lawrence MD, Bihari S, et al
    Lung surfactant in chronic heart failure patients.
    Int J Cardiol. 2016;207:213-214.
    PubMed     Text format    


  380. KAYA H, Beton O, Yilmaz MB
    Atrial fibrillation and D dimer levels for patients with acute decompensated heart failure.
    Int J Cardiol. 2016;207:136.
    PubMed     Text format    


  381. LIU M, Fang F, Luo XX, Shlomo BH, et al
    Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case-control study.
    Int J Cardiol. 2016;206:122-126.
    PubMed     Text format     Abstract available


  382. IMRAN TF, Shah R, Ha AS, Thomas R, et al
    Heart failure associated with small molecule tyrosine kinase inhibitors.
    Int J Cardiol. 2016;206:110-111.
    PubMed     Text format    


  383. LOPRINZI PD
    Objectively-measured physical activity and sleep apnea among congestive heart failure patients.
    Int J Cardiol. 2016;206:82-83.
    PubMed     Text format    


  384. BAVISHI C, Khan AR, Ather S
    Reply to the letter "Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality".
    Int J Cardiol. 2016;206:56-57.
    PubMed     Text format    


  385. FAN Z, Yang J, Yang J, Yang C, et al
    HDAC inhibition: A novel therapeutic approach for atherosclerosis.
    Int J Cardiol. 2016;202:722-3.
    PubMed     Text format    


  386. DONAZZAN L, Rigolli M, De Simone V, Bergamini C, et al
    Cardiac resynchronization therapy: Twelve-month effects of echocardiographic atrio-ventricular and inter-ventricular delay optimization. Rationale and design of the CARTEDO trial.
    Int J Cardiol. 2016;202:185-7.
    PubMed     Text format    


  387. HUANG JH, Lin YK, Hsieh MH, Chiu WC, et al
    Age and thyroid hormone replacement delays the recovery from amiodarone-induced hypothyroidism.
    Int J Cardiol. 2016;202:561-3.
    PubMed     Text format    


  388. LAINSCAK M, von Haehling S, Anker SD
    PURE muscle and more.
    Int J Cardiol. 2016;202:446-7.
    PubMed     Text format    


  389. SANTAS E, Nunez J
    Prognostic implications of pericardial effusion: The importance of underlying etiology.
    Int J Cardiol. 2016;202:407.
    PubMed     Text format    


  390. SOMMESE L, Valverde CA, Blanco P, Castro MC, et al
    Ryanodine receptor phosphorylation by CaMKII promotes spontaneous Ca(2+) release events in a rodent model of early stage diabetes: The arrhythmogenic substrate.
    Int J Cardiol. 2016;202:394-406.
    PubMed     Text format     Abstract available


    December 2015
  391. XIE W, Zheng F, Song X, Zhong B, et al
    Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis.
    Int J Cardiol. 2015;205:65-71.
    PubMed     Text format     Abstract available


  392. HIGASHI K, Murakami T, Ishikawa Y, Itoi T, et al
    Efficacy and safety of tolvaptan for pediatric patients with congestive heart failure. Multicenter survey in the working group of the Japanese Society of PEdiatric Circulation and Hemodynamics (J-SPECH).
    Int J Cardiol. 2015;205:37-42.
    PubMed     Text format     Abstract available


  393. DOKAINISH H, Teo K, Zhu J, Roy A, et al
    Heart Failure in Africa, Asia, the Middle East and South America: The INTER-CHF study.
    Int J Cardiol. 2015;204:133-141.
    PubMed     Text format     Abstract available


  394. EBNER N, Jankowska EA, Ponikowski P, Lainscak M, et al
    The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure.
    Int J Cardiol. 2015;205:6-12.
    PubMed     Text format     Abstract available


  395. CAPUANO A, Scavone C, Vitale C, Sportiello L, et al
    Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF).
    Int J Cardiol. 2015;200:15-9.
    PubMed     Text format     Abstract available


    November 2015
  396. DEMISSEI BG, Cleland JG, O'Connor CM, Metra M, et al
    Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients.
    Int J Cardiol. 2015;204:164-171.
    PubMed     Text format     Abstract available


  397. BANERJEE P
    Heart failure with preserved ejection fraction: A clinical crisis.
    Int J Cardiol. 2015;204:198-199.
    PubMed     Text format     Abstract available


  398. YOKOKAWA T, Sugano Y, Shimouchi A, Shibata A, et al
    A case of acute decompensated heart failure evaluated by series of exhaled acetone concentrations as noninvasive biomarker of heart failure severity.
    Int J Cardiol. 2015;204:112-113.
    PubMed     Text format    


  399. LUPON J, Sanders-van Wijk S, Januzzi JL, de Antonio M, et al
    Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study.
    Int J Cardiol. 2015;204:242-247.
    PubMed     Text format     Abstract available


  400. LEVICK SP, Melendez GC
    Targeting substance P and relaxin: A future combination therapy approach for heart failure?
    Int J Cardiol. 2015;204:154-155.
    PubMed     Text format    


  401. CONSUEGRA-SANCHEZ L, Jaulent-Huertas L, Vicente-Gilabert M, Escudero-Garcia G, et al
    Heart failure complicating acute myocardial infarction. Does the time of presentation matter?
    Int J Cardiol. 2015;204:48-50.
    PubMed     Text format    


  402. MINAMI Y, Haruki S, Jujo K, Itani R, et al
    Elevated D-dimer levels predict an adverse outcome in hospitalized patients with acute decompensated heart failure.
    Int J Cardiol. 2015;204:42-44.
    PubMed     Text format    


  403. GELLEN B, Canoui-Poitrine F, Boyer L, Drouot X, et al
    Apnea-hypopnea and desaturations in heart failure with reduced ejection fraction: Are we aiming at the right target?
    Int J Cardiol. 2015;203:1022-1028.
    PubMed     Text format     Abstract available


  404. LOPRINZI PD
    The association of serum cotinine and congestive heart failure diagnosis among never smokers: Considerations by physical activity behavior.
    Int J Cardiol. 2015;203:1042-1043.
    PubMed     Text format    


  405. TARGHER G, Dauriz M, Tavazzi L, Temporelli PL, et al
    Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry.
    Int J Cardiol. 2015;203:587-593.
    PubMed     Text format    


  406. LOPRINZI PD
    The effects of free-living physical activity on mortality after congestive heart failure diagnosis.
    Int J Cardiol. 2015;203:598-599.
    PubMed     Text format    


  407. BRUNO N, Ter Maaten JM, Ovchinnikova ES, Vegter EL, et al
    MicroRNAs relate to early worsening of renal function in patients with acute heart failure.
    Int J Cardiol. 2015;203:564-569.
    PubMed     Text format     Abstract available


  408. PALAU P, Dominguez E, Nunez E, Sanchis J, et al
    Six-minute walk test in moderate to severe heart failure with preserved ejection fraction: Useful for functional capacity assessment?
    Int J Cardiol. 2015;203:800-802.
    PubMed     Text format    


  409. BOSCHETTO P, Vaccari A, Groccia R, Casimirri E, et al
    Forced expiratory volume in one second: Predicting return to work within 3months after chronic heart failure diagnosis.
    Int J Cardiol. 2015;203:798-799.
    PubMed     Text format    


  410. MUELLER KA, Schwille J, Vollmer S, Ehinger E, et al
    Prognostic impact of macrophage migration inhibitory factor in patients with non-ischemic heart failure undergoing endomyocardial biopsy.
    Int J Cardiol. 2015;203:656-659.
    PubMed     Text format    


  411. CORRA U, Agostoni P, Giordano A, Cattadori G, et al
    The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study.
    Int J Cardiol. 2015;203:1067-1072.
    PubMed     Text format     Abstract available


  412. KITAMURA M, Mimura Y, Taniue H, Yoshitake K, et al
    Predictors of independent walking at hospital discharge in elderly heart failure patients.
    Int J Cardiol. 2015;203:609-611.
    PubMed     Text format    


  413. KOEHLER U, Kesper K, Timmesfeld N, Grimm W, et al
    Cheyne-Stokes respiration in patients with heart failure.
    Int J Cardiol. 2015;203:775-778.
    PubMed     Text format    


  414. LOPATIN YM, Rosano GM, Fragasso G, Lopaschuk GD, et al
    Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure.
    Int J Cardiol. 2015;203:909-915.
    PubMed     Text format     Abstract available


  415. BROUWERS C, Christensen SB, Damen NL, Denollet J, et al
    Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression.
    Int J Cardiol. 2015;203:867-873.
    PubMed     Text format     Abstract available


    October 2015
  416. MESSIAS LR, Messias AC, de Miranda SM, Wiefels CC, et al
    Abnormal adrenergic activation is the major determinant of reduced functional capacity in heart failure with preserved ejection fraction.
    Int J Cardiol. 2015;203:900-902.
    PubMed     Text format    


  417. MAYER O JR, Seidlerova J, Vanek J, Karnosova P, et al
    The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease.
    Int J Cardiol. 2015;203:916-922.
    PubMed     Text format     Abstract available


  418. BOWEN TS, Eisenkolb S, Werner S, Schwarzer M, et al
    Inheriting a high aerobic fitness predisposes to skeletal muscle and endothelial dysfunction in chronic heart failure.
    Int J Cardiol. 2015;203:353-356.
    PubMed     Text format    


  419. EYUBOGLU M
    Device therapy and aldosterone antagonists in the prognosis of heart failure.
    Int J Cardiol. 2015 Oct 28. pii: S0167-5273(15)30763.
    PubMed     Text format    


  420. KOTECHA D, Chudasama R, Lane DA, Kirchhof P, et al
    Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes.
    Int J Cardiol. 2015;203:660-666.
    PubMed     Text format     Abstract available


  421. ROBLEK T, Deticek A, Leskovar B, Suskovic S, et al
    Clinical-pharmacist intervention reduces clinically relevant drug-drug interactions in patients with heart failure: A randomized, double-blind, controlled trial.
    Int J Cardiol. 2015;203:647-652.
    PubMed     Text format     Abstract available


  422. NYMO SH, Ueland T, Askevold E, Dahl CP, et al
    Circulating nucleosomes in chronic heart failure.
    Int J Cardiol. 2015;203:742-743.
    PubMed     Text format    


  423. YANG J, Fan Z, Yang J, Yang C, et al
    Relaxin: A novel therapy for acute heart failure.
    Int J Cardiol. 2015 Oct 27. pii: S0167-5273(15)30760.
    PubMed     Text format    


  424. GEMES K, Janszky I, Ahnve S, Laszlo KD, et al
    Light-to-moderate drinking and incident heart failure - the Norwegian HUNT study.
    Int J Cardiol. 2015;203:553-560.
    PubMed     Text format     Abstract available


  425. BARRA S, Providencia R, Agarwal S
    Do we need further clinical-effectiveness estimates to support the use of primary prevention implantable cardioverter-defibrillators in New York Heart Association class III patients?
    Int J Cardiol. 2015;203:184-186.
    PubMed     Text format    


  426. HE WM, Luo YT, Shui X, Liao XX, et al
    Critical appraisal of international guidelines on chronic heart failure: Can China AGREE?
    Int J Cardiol. 2015;203:111-114.
    PubMed     Text format    


  427. BEHNES M, Bertsch T, Weiss C, Ahmad-Nejad P, et al
    Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.
    Int J Cardiol. 2015;203:398-406.
    PubMed     Text format    


  428. FARMAKIS D, Stafylas P, Giamouzis G, Maniadakis N, et al
    The medical and socioeconomic burden of heart failure: A comparative delineation with cancer.
    Int J Cardiol. 2015;203:279-281.
    PubMed     Text format     Abstract available


  429. LOURENCO P, Ribeiro A, Cunha FM, Pintalhao M, et al
    Is there a heart rate paradox in acute heart failure?
    Int J Cardiol. 2015;203:409-414.
    PubMed     Text format    


  430. HAMMER F, Deutschbein T, Marx A, Guder G, et al
    High evening salivary cortisol is an independent predictor of increased mortality risk in patients with systolic heart failure.
    Int J Cardiol. 2015;203:69-73.
    PubMed     Text format     Abstract available


  431. CHEN Y, Huang W, Huang Y, Hu Y, et al
    Beta-blockers treatment in heart failure with atrial fibrillation - Who should we believe?
    Int J Cardiol. 2015;203:60-61.
    PubMed     Text format    


  432. MA H, Wang X, Xie H, Sun C, et al
    Characterization of the cardiac venous system in heart failure patients using 256-slice CT.
    Int J Cardiol. 2015;203:447-448.
    PubMed     Text format    


  433. LIN YS, Tung TH, Wang J, Chen YF, et al
    Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.
    Int J Cardiol. 2015;203:204-211.
    PubMed     Text format     Abstract available


  434. GUVENC TS, Ekmekci A, Sargin M, Orhan G, et al
    Rapid improvement of pulmonary hemodynamics following combined tadalafil and inotropic treatment in a patient with pulmonary hypertension secondary to left ventricular dysfunction.
    Int J Cardiol. 2015;203:212-213.
    PubMed     Text format    


  435. ZACHARIAS M, Joffe S, Konadu E, Meyer T, et al
    Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients.
    Int J Cardiol. 2015;202:918-921.
    PubMed     Text format     Abstract available


  436. BIRGY C, Bresson D, Duculescu E, Carpentier M, et al
    Rare and life-threatening cardiovascular complication of chronic thromboembolic pulmonary hypertension diagnosed by trans-thoracic echocardiography.
    Int J Cardiol. 2015;203:450-452.
    PubMed     Text format    


  437. PETERS S
    Focal form of left ventricular non-compaction cardiomyopathy with congestive form of heart failure.
    Int J Cardiol. 2015;202:879.
    PubMed     Text format    


  438. ZENGIN E, Sinning C, Schrage B, Mueller GC, et al
    Right heart failure in pregnant women with cyanotic congenital heart disease - The good, the bad and the ugly.
    Int J Cardiol. 2015;202:773-775.
    PubMed     Text format    


  439. SHIRAISHI Y, Sawano M, Kohno T, Nishiyama T, et al
    Validation of the Seattle Heart Failure Model in Japanese heart failure patients.
    Int J Cardiol. 2015;203:87-89.
    PubMed     Text format    


  440. HOPPER I, Skiba M, Windebank E, Brack J, et al
    Polypharmacy in heart failure - Is reducing medication safe?
    Int J Cardiol. 2015 Oct 9. pii: S0167-5273(15)30533.
    PubMed     Text format    


  441. CHEN J, Stein S, Molina M, Owens A, et al
    Right heart size in orthotopic heart transplant population: Influence of donor and recipient gender, race, and body surface area.
    Int J Cardiol. 2015;203:105-106.
    PubMed     Text format    


    September 2015
  442. MIZUNO A, Ohde S, Hayashi A, Nakamura M, et al
    The differences of advance decision making between hospitalized patients with heart failure and malignant disease.
    Int J Cardiol. 2015;202:649-651.
    PubMed     Text format    


  443. HUANG Y, Huang W, Hu Y
    Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality?
    Int J Cardiol. 2015 Sep 27. pii: S0167-5273(15)30521.
    PubMed     Text format    


  444. VICENZI M, Deboeck G, Faoro V, Loison J, et al
    Exercise oscillatory ventilation in heart failure and in pulmonary arterial hypertension.
    Int J Cardiol. 2015;202:736-740.
    PubMed     Text format     Abstract available


  445. WANG J, Fang F, Yip GW, Sanderson JE, et al
    Importance of chronotropic response and left ventricular long-axis function for exercise performance in patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2015;202:339-343.
    PubMed     Text format     Abstract available


  446. ALTER P, Koczulla AR, Nell C, Figiel JH, et al
    Wall stress determines systolic and diastolic function - Characteristics of heart failure.
    Int J Cardiol. 2015;202:685-693.
    PubMed     Text format     Abstract available


  447. ZHANG J, Hobkirk J, Carroll S, Pellicori P, et al
    Exploring quality of life in patients with and without heart failure.
    Int J Cardiol. 2015;202:676-684.
    PubMed     Text format     Abstract available


  448. LINDE C, Curtis AB, Fonarow GC, Lee K, et al
    Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study.
    Int J Cardiol. 2015;202:349-355.
    PubMed     Text format     Abstract available


  449. FANG F, Liu W, Zhao YX, Yang Y, et al
    The patient's selection of PARACHUTE(R) endoventricular partitioning device: The important role of detailed echocardiography.
    Int J Cardiol. 2015;195:176-9.
    PubMed     Text format    


  450. GIANNONI A, Raglianti V, Mirizzi G, Taddei C, et al
    Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure.
    Int J Cardiol. 2015;202:200-206.
    PubMed     Text format     Abstract available


  451. DHOBLE A, Kashif M, Chakravarty T, Jilaihawi H, et al
    Transcatheter tricuspid valve replacement along with tricuspid paravalvular leak closure in a patient with severe right heart failure and previous transcatheter pulmonary valve replacement.
    Int J Cardiol. 2015;202:198-199.
    PubMed     Text format    


  452. ROBLES-MEZCUA A, Gonzalez-Cruces N, Ruiz-Salas A, Morcillo-Hidalgo L, et al
    Efficacy, safety and prognostic benefit of intravenous iron therapy with ferric carboxymaltose in patients with heart failure and left ventricular dysfunction.
    Int J Cardiol. 2015;202:118-120.
    PubMed     Text format    


  453. PAREEK M, Nielsen ML, Leosdottir M, Nilsson PM, et al
    Response to the letter by Tomoyuki Kawada: Diastolic function, fasting plasma glucose and left ventricular mass index.
    Int J Cardiol. 2015;194:58-9.
    PubMed     Text format    


    August 2015
  454. KELLER-ROSS ML, Johnson BD, Carter RE, Joyner MJ, et al
    Improved Ventilatory Efficiency with Locomotor Muscle Afferent Inhibition is Strongly Associated with Leg Composition in Heart Failure.
    Int J Cardiol. 2015;202:159-166.
    PubMed     Text format     Abstract available


  455. SILVETTI S, Nieminen MS
    Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis.
    Int J Cardiol. 2015;202:138-143.
    PubMed     Text format     Abstract available


  456. SPINAR J, Jarkovsky J, Spinarova L, Mebazaa A, et al
    AHEAD score - Long-term risk classification in acute heart failure.
    Int J Cardiol. 2015;202:21-26.
    PubMed     Text format     Abstract available


  457. MAGRI D, Banfi C, Maruotti A, Farina S, et al
    Plasma immature form of surfactant protein type B correlates with prognosis in patients with chronic heart failure. A pilot single-center prospective study.
    Int J Cardiol. 2015;201:394-399.
    PubMed     Text format     Abstract available


  458. KAWADA T
    Diastolic function, fasting plasma glucose and left ventricular mass index.
    Int J Cardiol. 2015;193:58.
    PubMed     Text format    


  459. BUSSEY CT, Hughes G, Saxena P, Galvin IF, et al
    Chamber-specific changes in calcium-handling proteins in the type 2 diabetic human heart with preserved ejection fraction.
    Int J Cardiol. 2015;193:53-5.
    PubMed     Text format    


  460. VAN ITERSON EH, Snyder EM, Joyner MJ, Johnson BD, et al
    Intrathecal fentanyl blockade of afferent neural feedback from skeletal muscle during exercise in heart failure patients: Influence on circulatory power and pulmonary vascular capacitance.
    Int J Cardiol. 2015;201:384-393.
    PubMed     Text format     Abstract available


  461. DOEHNER W, Jankowska EA, Springer J, Lainscak M, et al
    Uric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications.
    Int J Cardiol. 2015 Aug 11. pii: S0167-5273(15)30319.
    PubMed     Text format     Abstract available


  462. WEIDMANN ZM, Breidthardt T, Twerenbold R, Zusli C, et al
    Prediction of mortality using quantification of renal function in acute heart failure.
    Int J Cardiol. 2015;201:650-657.
    PubMed     Text format     Abstract available


  463. MARU S, Byrnes J, Carrington MJ, Chan YK, et al
    Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Frien
    Int J Cardiol. 2015;201:368-375.
    PubMed     Text format     Abstract available


  464. FARMAKIS D, Parissis J, Karavidas A, Karvounis C, et al
    In-hospital management of acute heart failure: Practical recommendations and future perspectives.
    Int J Cardiol. 2015;201:231-236.
    PubMed     Text format     Abstract available


  465. KAJIMOTO K, Sato N, Takano T
    Relation between elevated blood urea nitrogen, clinical features or comorbidities, and clinical outcome in patients hospitalized for acute heart failure syndromes.
    Int J Cardiol. 2015;201:311-314.
    PubMed     Text format    


  466. LU Y, Zhang L, Zhou X, Tang B, et al
    Renal sympathetic denervation: A potential alternative strategy for managing patients with heart failure.
    Int J Cardiol. 2015;201:140-141.
    PubMed     Text format    


  467. GOTZ N, Patzelt J, Seizer P, Walker T, et al
    Percutaneous mitral valve repair (PMVR) in a patient with recurrence of mitral regurgitation 17years after surgical reconstruction.
    Int J Cardiol. 2015;201:321-323.
    PubMed     Text format    


  468. TAKAHASHI M, Kinugawa S, Takada S, Hirabayashi K, et al
    Low-intensity exercise under ischemic conditions enhances metabolic stress in patients with heart failure.
    Int J Cardiol. 2015;201:142-144.
    PubMed     Text format    


    July 2015
  469. TAKEUCHI T, Dohi K, Omori T, Moriwaki K, et al
    Diuretic effects of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and heart failure.
    Int J Cardiol. 2015;201:1-3.
    PubMed     Text format    


  470. YAMAZOE M, Mizuno A, Niwa K, Isobe M, et al
    Edema index measured by bioelectrical impedance analysis as a predictor of fluid reduction needed to remove clinical congestion in acute heart failure.
    Int J Cardiol. 2015;201:190-192.
    PubMed     Text format    


  471. SAVARESE G, Edner M, Dahlstrom U, Perrone-Filardi P, et al
    Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.
    Int J Cardiol. 2015;199:415-423.
    PubMed     Text format     Abstract available


  472. SMOLIS-BAK E, Dabrowski R, Piotrowicz E, Chwyczko T, et al
    Hospital-based and telemonitoring guided home-based training programs: Effects on exercise tolerance and quality of life in patients with heart failure (NYHA class III) and cardiac resynchronization therapy. A randomized, prospective observation.
    Int J Cardiol. 2015;199:442-447.
    PubMed     Text format     Abstract available


  473. PETERS S
    Prognostic value of epsilon waves in lead aVR in arrhythmogenic cardiomyopathy.
    Int J Cardiol. 2015;191:77-8.
    PubMed     Text format    


  474. LAI KB, Sanderson JE, Izzat MB, Yu CM, et al
    Micro-RNA and mRNA myocardial tissue expression in biopsy specimen from patients with heart failure.
    Int J Cardiol. 2015;199:79-83.
    PubMed     Text format     Abstract available


  475. GAYAT E, Caillard A, Laribi S, Mueller C, et al
    Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure.
    Int J Cardiol. 2015;199:241-247.
    PubMed     Text format     Abstract available


  476. MASUDA M, Yamada T, Mizuno H, Minamiguchi H, et al
    Impact of atrial fibrillation ablation on cardiac sympathetic nervous system in patients with and without heart failure.
    Int J Cardiol. 2015;199:65-70.
    PubMed     Text format     Abstract available


  477. CHEN M, Yu L, Sheng X, Liu Q, et al
    Cardiac autonomic tone modulators: Promising feasible options for heart failure with hyper-sympathetic activity.
    Int J Cardiol. 2015;198:185-186.
    PubMed     Text format    


  478. ANTONIOU CK, Chrysohoou C, Lerakis S, Manolakou P, et al
    Effects of ventriculoarterial coupling changes on renal function, echocardiographic indices and energy efficiency in patients with acute decompensated systolic heart failure under furosemide and dopamine treatment: A comparison of three therapeutic pr
    Int J Cardiol. 2015;199:44-49.
    PubMed     Text format     Abstract available


  479. DANDEL M, Krabatsch T, Falk V
    Left ventricular vs. biventricular mechanical support: Decision making and strategies for avoidance of right heart failure after left ventricular assist device implantation.
    Int J Cardiol. 2015;198:241-250.
    PubMed     Text format     Abstract available


    June 2015
  480. EYUBOGLU M
    How can we detect the low risk patients for ischemic etiology in heart failure population?
    Int J Cardiol. 2015;197:1.
    PubMed     Text format    


  481. WANG X, Peng J, Xie X, Qian J, et al
    Tricuspid regurgitation predicts cardiorenal syndrome in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2015;197:83-84.
    PubMed     Text format    


  482. RADEMAKER MT, Ellmers LJ, Charles CJ, Mark Richards A, et al
    Urocortin 2 protects heart and kidney structure and function in an ovine model of acute decompensated heart failure: Comparison with dobutamine.
    Int J Cardiol. 2015;197:56-65.
    PubMed     Text format     Abstract available


  483. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
    Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality".
    Int J Cardiol. 2015;189:247-8.
    PubMed     Text format    


  484. KRACHLER B, Savonen K, Komulainen P, Hassinen M, et al
    VO2max/kg is expected to be lower in obese individuals!
    Int J Cardiol. 2015;189:234.
    PubMed     Text format    


  485. RUSHTON CA, Satchithananda DK, Jones PW, Kadam UT, et al
    Non-cardiovascular comorbidity, severity and prognosis in non-selected heart failure populations: A systematic review and meta-analysis.
    Int J Cardiol. 2015;196:98-106.
    PubMed     Text format     Abstract available


  486. FARAG M, Mabote T, Shoaib A, Zhang J, et al
    Hydralazine and nitrates alone or combined for the management of chronic heart failure: A systematic review.
    Int J Cardiol. 2015;196:61-69.
    PubMed     Text format     Abstract available


  487. TOPCU S, Aksu U, Tanboga IH, Sevimli S, et al
    Giant left ventricle pseudoaneurysm that caused heart failure.
    Int J Cardiol. 2015;196:34-35.
    PubMed     Text format    


  488. MAKINO J, Kohsaka S, Shiraishi Y, Inohara T, et al
    Application of the United States acute heart failure risk prediction model in Japanese patients; analysis from a contemporary multicenter registry.
    Int J Cardiol. 2015;195:323-325.
    PubMed     Text format    


    May 2015
  489. ALVELOS M, Couto M, Laszczynska O, Almeida PB, et al
    Measuring renal function in acute heart failure: A place for old and new equations.
    Int J Cardiol. 2015;196:70-72.
    PubMed     Text format    


  490. HELSEN F, De Meester P, Van Keer J, Gabriels C, et al
    Pulmonary outflow obstruction protects against heart failure in adults with congenitally corrected transposition of the great arteries.
    Int J Cardiol. 2015;196:1-6.
    PubMed     Text format     Abstract available


  491. LIM HS, Andrianopoulos N, Sugumar H, Stub D, et al
    Long-term survival of elderly patients undergoing percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock.
    Int J Cardiol. 2015;195:259-264.
    PubMed     Text format     Abstract available


  492. VOLTERRANI M, Iellamo F
    Eplerenone in chronic heart failure with depressed systolic function.
    Int J Cardiol. 2015 May 21. pii: S0167-5273(15)01189.
    PubMed     Text format     Abstract available


  493. SCHOU M, Bosselmann H, Gaborit F, Iversen K, et al
    Iron deficiency: Prevalence and relation to cardiovascular biomarkers in heart failure outpatients.
    Int J Cardiol. 2015;195:143-148.
    PubMed     Text format     Abstract available


  494. MA Z, Fang F, Chui KL, Chen T, et al
    A Rare Etiology of Severe Acute Heart Failure: Subacute Spinal Subdural Hematoma in a Young Woman.
    Int J Cardiol. 2015;195:61-63.
    PubMed     Text format    


  495. FREA S, Bovolo V, Pidello S, Canavosio FG, et al
    Clinical and prognostic role of ammonia in advanced decompensated heart failure. The cardio-abdominal syndrome?
    Int J Cardiol. 2015;195:53-60.
    PubMed     Text format     Abstract available


  496. JAGODZINSKI A, Havulinna AS, Appelbaum S, Zeller T, et al
    Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.
    Int J Cardiol. 2015;192:33-39.
    PubMed     Text format     Abstract available


  497. BRUNETTI ND, Correale M, Totaro A, Ferraretti A, et al
    Lower cardiovascular mortality with atorvastatin and rosuvastatin vs simvastatin: Data from "moderate-intensity" statin users in an observational registry on chronic heart failure (Daunia Heart Failure Registry).
    Int J Cardiol. 2015;194:23-27.
    PubMed     Text format    


  498. KATO S, Saito N, Kirigaya H, Gyotoku D, et al
    Prognostic significance of quantitative assessment of focal myocardial fibrosis in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2015;191:314-319.
    PubMed     Text format     Abstract available


  499. KALUZA J, Akesson A, Wolk A
    Long-term processed and unprocessed red meat consumption and risk of heart failure: A prospective cohort study of women.
    Int J Cardiol. 2015;193:42-46.
    PubMed     Text format     Abstract available


  500. AKSU U, Topcu S
    Giant right atrium due to rheumatic tricuspid valve stenosis.
    Int J Cardiol. 2015;193:47-48.
    PubMed     Text format    


  501. AKSU U, Kalkan K
    Pericardial effusion and heart failure.
    Int J Cardiol. 2015;192:21.
    PubMed     Text format    


  502. NTALIANIS A, Kapelios CJ, Kanakakis J, Repasos E, et al
    Prolonged intra-aortic balloon pump support in biventricular heart failure induces right ventricular reverse remodeling.
    Int J Cardiol. 2015;192:3-8.
    PubMed     Text format     Abstract available


  503. SMEETS M, Degryse J, Aertgeerts B, Janssens S, et al
    General practitioners' judgement of chronic heart failure in the oldest old: Insights from the BELFRAIL study.
    Int J Cardiol. 2015;191:120-127.
    PubMed     Text format     Abstract available


  504. KAUFMANN BA, Goetschalckx K, Min SY, Maeder MT, et al
    Improvement in left ventricular ejection fraction and reverse remodeling in elderly heart failure patients on intense NT-proBNP-guided therapy.
    Int J Cardiol. 2015;191:286-293.
    PubMed     Text format     Abstract available


  505. OH PC, Koh KK, Shin J, Yu J, et al
    Stress-induced cardiomyopathy presented with acute decompensated heart failure.
    Int J Cardiol. 2015;191:114-116.
    PubMed     Text format    


  506. KAJIMOTO K, Sato N, Takano T
    Association of age and baseline systolic blood pressure with outcomes in patients hospitalized for acute heart failure syndromes.
    Int J Cardiol. 2015;191:100-106.
    PubMed     Text format     Abstract available


  507. GUDER G, Stork S
    The role of circulatory power and cardiac reserve in reverse epidemiology - Assessing heart failure severity.
    Int J Cardiol. 2015;191:48-49.
    PubMed     Text format    


  508. SOUZA FC, Neri JS, Marques EB, Barros RB, et al
    Should pharmacotherapy of digoxin be reviewed in male patients with heart failure in the case of association with carvedilol?
    Int J Cardiol. 2015;191:4-6.
    PubMed     Text format    


  509. NIEMINEN MS, Dickstein K, Fonseca C, Serrano JM, et al
    The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations.
    Int J Cardiol. 2015;191:256-264.
    PubMed     Text format     Abstract available


  510. KIRAT T, Kose N
    Response to the letter by Akinori Sairaku et al.: Different mechanisms = synergic effect.
    Int J Cardiol. 2015;186:148.
    PubMed     Text format    


    April 2015
  511. THANG ND, Karlson BW, Sundstrom BW, Karlsson T, et al
    Pre-hospital prediction of death or cardiovascular complications during hospitalisation and death within one year in suspected acute coronary syndrome patients.
    Int J Cardiol. 2015;185:308-12.
    PubMed     Text format     Abstract available


  512. OHLOW MA, von Korn H, Lauer B
    Characteristics and outcome of congenital left ventricular aneurysm and diverticulum: Analysis of 809 cases published since 1816.
    Int J Cardiol. 2015;185:34-45.
    PubMed     Text format     Abstract available


  513. IYISOY A, Ozturk C, Unlu M, Celik T, et al
    Cardiac resynchronization therapy in a patient with percutaneous mitral annuloplasty and prior aortic valve surgery.
    Int J Cardiol. 2015;187:532-533.
    PubMed     Text format    


  514. HUANG B, Yu L, Zhou L, Jiang H, et al
    Renal denervation for the treatment of atrial fibrillation in hypertensive patients or beyond?
    Int J Cardiol. 2015;189:59-60.
    PubMed     Text format    


  515. RAFIQ I, Freeman LJ
    Pulsed levosimendan therapy in the management of chronic end stage cardiac failure in 'adult congenital heart disease'.
    Int J Cardiol. 2015;195:283-284.
    PubMed     Text format    


  516. YILDIZ A, Soydinc S
    Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality.
    Int J Cardiol. 2015;184:512-3.
    PubMed     Text format    


  517. MORETTI C, Grosso Marra W, D'Ascenzo F, Omede P, et al
    Beta blocker for patients with pulmonary arterial hypertension: A single center experience.
    Int J Cardiol. 2015;184:528-32.
    PubMed     Text format    


  518. PAREEK M, Nielsen ML, Gerke O, Leosdottir M, et al
    Worsening diastolic function is associated with elevated fasting plasma glucose and increased left ventricular mass in a supra-additive fashion in an elderly, healthy, Swedish population.
    Int J Cardiol. 2015;184:466-72.
    PubMed     Text format     Abstract available


  519. EINDHOVEN JA, Roos-Hesselink JW, van den Bosch AE, Kardys I, et al
    High-sensitive troponin-T in adult congenital heart disease.
    Int J Cardiol. 2015;184:405-11.
    PubMed     Text format     Abstract available


  520. OHUCHI H, Negishi J, Hayama Y, Sasaki O, et al
    Hyperuricemia reflects global Fontan pathophysiology and associates with morbidity and mortality in patients after the Fontan operation.
    Int J Cardiol. 2015;184:623-30.
    PubMed     Text format     Abstract available


  521. LUMENS J, Vernooy K
    Better understanding before implanting.
    Int J Cardiol. 2015;184:6-8.
    PubMed     Text format    


    March 2015
  522. ZHU Z, Hu X, Fang Z, Zhou S, et al
    Endothelial cell is critical in HMGB1 mediated cardiac impairment in ischemic heart disease.
    Int J Cardiol. 2015;187:39-40.
    PubMed     Text format    


  523. WHITE JM, Khalique OK, Kodali SK
    Immediate, same-setting paravalvular leak closure following transcatheter aortic valve replacement.
    Int J Cardiol. 2015;189:235-237.
    PubMed     Text format    


  524. YAP LB, Qadir F, Nguyen ST, Ma SK, et al
    The clinical benefit of cardiac resynchronization therapy for narrow QRS compared to broad QRS complex patients.
    Int J Cardiol. 2015;183:178-9.
    PubMed     Text format    


  525. KUSCHYK J, Roeger S, Schneider R, Streitner F, et al
    Efficacy and survival in patients with cardiac contractility modulation: long-term single center experience in 81 patients.
    Int J Cardiol. 2015;183:76-81.
    PubMed     Text format     Abstract available


  526. BARGE-CABALLERO E, Segovia-Cubero J, Gonzalez-Vilchez F, Delgado-Jimenez J, et al
    Evaluation of the preoperative vasoactive-inotropic score as a predictor of postoperative outcomes in patients undergoing heart transplantation.
    Int J Cardiol. 2015;185:192-194.
    PubMed     Text format    


  527. GEREDE DM, Sayin T, Vurgun VK, Akbulut IM, et al
    Dramatic improvement of clinical and hemodynamic parameters of a heart transplant candidate with sildenafil treatment.
    Int J Cardiol. 2015;185:148-149.
    PubMed     Text format    


  528. CIPRIANI M, Ammirati E, Landolina M, Oliva F, et al
    Cumulative analysis on 4802 patients confirming that women benefit more than men from cardiac resynchronization therapy.
    Int J Cardiol. 2015;182:454-6.
    PubMed     Text format    


  529. VON BIBRA H, Paulus WJ, St John Sutton M, Leclerque C, et al
    Quantification of diastolic dysfunction via the age dependence of diastolic function - impact of insulin resistance with and without type 2 diabetes.
    Int J Cardiol. 2015;182:368-74.
    PubMed     Text format     Abstract available


  530. BALLO P, Fantini A, Vannelli P, Fibbi V, et al
    A resynchronized shunt: Biventricular pacing followed by acute clinical decompensation in a patient with misdiagnosed atrial septal defect.
    Int J Cardiol. 2015;182:288-90.
    PubMed     Text format    


  531. LESZEK P, Sochanowicz B, Brzoska K, Danko B, et al
    Does myocardial iron load determine the severity of heart insufficiency?
    Int J Cardiol. 2015;182:191-3.
    PubMed     Text format    


  532. POPPE KK, Whalley GA, Doughty RN, Woodward M, et al
    The development and feasibility of a composite score of echocardiographic indices that may stratify outcome in patients with diabetes mellitus.
    Int J Cardiol. 2015;182:244-9.
    PubMed     Text format     Abstract available


    February 2015
  533. NAKAJIMA M, Takada A, Maeda H, Saito K, et al
    Near-miss of ruptured myocardial infarction and catheter ablation injury associated with lethal cardiac tamponade.
    Int J Cardiol. 2015;201:336-338.
    PubMed     Text format    


  534. HELLENKAMP K, Darius H, Giannitsis E, Erbel R, et al
    The German CPU Registry: Dyspnea independently predicts negative short-term outcome in patients admitted to German Chest Pain Units.
    Int J Cardiol. 2015;181:88-95.
    PubMed     Text format     Abstract available


  535. FINEGOLD J, Bordachar P, Kyriacou A, Sohaib SM, et al
    Atrioventricular delay optimization of cardiac resynchronisation therapy: comparison of non-invasive blood pressure with invasive haemodynamic measures.
    Int J Cardiol. 2015;180:221-2.
    PubMed     Text format    


    January 2015
  536. LATTUCA B, Roubille F
    Ivabradine: a promising drug in cardiogenic shock to prevent the undesirable sinus tachycardia induced by dobutamine?
    Int J Cardiol. 2015;178:308-10.
    PubMed     Text format    


  537. SHIUE I, Perkins DR, Bearman N
    Postprocedural disorders of circulatory system admissions peaked at physically equivalent temperature 0-10 degrees C in Germany in 2009-2011.
    Int J Cardiol. 2015;178:10-1.
    PubMed     Text format    


  538. WANG BH, von Lueder TG, Kompa AR, Huang L, et al
    Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis.
    Int J Cardiol. 2015;186:104-5.
    PubMed     Text format    


  539. NAPP LC, Brehm M, Kuhn C, Schafer A, et al
    Heart against veno-arterial ECMO: Competition visualized.
    Int J Cardiol. 2015;187:164-5.
    PubMed     Text format    


  540. RODRIGUEZ Y, Nan J, Yasin O, Gorcsan J 3rd, et al
    The impact of a strategy of image-guided left ventricular lead placement during cardiac resynchronization therapy on health care utilization.
    Int J Cardiol. 2015;187:311-2.
    PubMed     Text format    


  541. TAN DK, Hothi SS, Macdonald W, Schlosshan D, et al
    Impacts of valve intervention on the Functional REServe of the Heart: The FRESH-valve pilot study.
    Int J Cardiol. 2015;187:491-501.
    PubMed     Text format     Abstract available


    December 2014
  542. KORANTZOPOULOS P
    Maneuvers to eliminate loss of biventricular pacing due to T-wave oversensing.
    Int J Cardiol. 2014;177:523.
    PubMed     Text format    


    November 2014
  543. GREVE AM, Bang CN, Berg RM, Egstrup K, et al
    Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: The SEAS study.
    Int J Cardiol. 2014;180C:122-128.
    PubMed     Text format     Abstract available


  544. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
    Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
    Int J Cardiol. 2014;180C:1-5.
    PubMed     Text format     Abstract available


    October 2014
  545. ABUHAB A, Bacal F
    Cost-effectiveness analysis of Chagas' cardiomyopathy: early diagnosis and prevention should be the target for comparison.
    Int J Cardiol. 2014;176:1238.
    PubMed     Text format    


    August 2014
  546. SINGHAL R, Chang SL, Chong E, Hsiao YW, et al
    Colchicine suppresses atrial fibrillation in failing heart.
    Int J Cardiol. 2014 Aug 17. pii: S0167-5273(14)01277.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: